RU2500677C2 - Производные замещенного индола - Google Patents
Производные замещенного индола Download PDFInfo
- Publication number
- RU2500677C2 RU2500677C2 RU2010138838/04A RU2010138838A RU2500677C2 RU 2500677 C2 RU2500677 C2 RU 2500677C2 RU 2010138838/04 A RU2010138838/04 A RU 2010138838/04A RU 2010138838 A RU2010138838 A RU 2010138838A RU 2500677 C2 RU2500677 C2 RU 2500677C2
- Authority
- RU
- Russia
- Prior art keywords
- methyl
- dimethylamino
- indol
- piperidin
- phenylpiperidin
- Prior art date
Links
- 150000002475 indoles Chemical class 0.000 title claims abstract 15
- 229940054051 antipsychotic indole derivative Drugs 0.000 title abstract 2
- 125000001041 indolyl group Chemical group 0.000 claims abstract 6
- 238000000034 method Methods 0.000 claims abstract 2
- 108010020615 nociceptin receptor Proteins 0.000 claims abstract 2
- 239000000126 substance Substances 0.000 claims abstract 2
- -1 cyclic aromatic radical Chemical class 0.000 claims 35
- 125000000217 alkyl group Chemical group 0.000 claims 13
- 125000003118 aryl group Chemical group 0.000 claims 11
- SIKJAQJRHWYJAI-UHFFFAOYSA-N benzopyrrole Natural products C1=CC=C2NC=CC2=C1 SIKJAQJRHWYJAI-UHFFFAOYSA-N 0.000 claims 10
- PZOUSPYUWWUPPK-UHFFFAOYSA-N indole Natural products CC1=CC=CC2=C1C=CN2 PZOUSPYUWWUPPK-UHFFFAOYSA-N 0.000 claims 10
- RKJUIXBNRJVNHR-UHFFFAOYSA-N indolenine Natural products C1=CC=C2CC=NC2=C1 RKJUIXBNRJVNHR-UHFFFAOYSA-N 0.000 claims 10
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 claims 9
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 claims 9
- 150000001875 compounds Chemical class 0.000 claims 7
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 claims 6
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims 6
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 claims 6
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 claims 6
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 claims 6
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 claims 6
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 claims 6
- QTBSBXVTEAMEQO-UHFFFAOYSA-N acetic acid Substances CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 claims 6
- 125000001072 heteroaryl group Chemical group 0.000 claims 5
- 150000003254 radicals Chemical class 0.000 claims 5
- 229920006395 saturated elastomer Polymers 0.000 claims 5
- DAVFFANIZHZZJR-UHFFFAOYSA-N 1-[2-[(5-methoxy-1h-indol-3-yl)methyl-methylamino]ethyl]-n,n-dimethyl-4-phenylpiperidin-4-amine Chemical compound C12=CC(OC)=CC=C2NC=C1CN(C)CCN(CC1)CCC1(N(C)C)C1=CC=CC=C1 DAVFFANIZHZZJR-UHFFFAOYSA-N 0.000 claims 4
- QOSSAOTZNIDXMA-UHFFFAOYSA-N Dicylcohexylcarbodiimide Chemical compound C1CCCCC1N=C=NC1CCCCC1 QOSSAOTZNIDXMA-UHFFFAOYSA-N 0.000 claims 4
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 claims 4
- 239000002253 acid Substances 0.000 claims 4
- 239000003814 drug Substances 0.000 claims 4
- 125000005842 heteroatom Chemical group 0.000 claims 4
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 claims 4
- 125000001424 substituent group Chemical group 0.000 claims 4
- 208000002193 Pain Diseases 0.000 claims 3
- 150000007513 acids Chemical class 0.000 claims 3
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 claims 3
- 150000002391 heterocyclic compounds Chemical class 0.000 claims 3
- 125000000814 indol-3-yl group Chemical group [H]C1=C([H])C([H])=C2N([H])C([H])=C([*])C2=C1[H] 0.000 claims 3
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims 3
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 claims 3
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 claims 2
- SDYYCZGLHXWYAP-UHFFFAOYSA-N 1-[2-[(1,2-dimethylindol-3-yl)methyl-methylamino]ethyl]-n,n-dimethyl-4-phenylpiperidin-4-amine Chemical compound CC=1N(C)C2=CC=CC=C2C=1CN(C)CCN(CC1)CCC1(N(C)C)C1=CC=CC=C1 SDYYCZGLHXWYAP-UHFFFAOYSA-N 0.000 claims 2
- LYGPZEATHDSVTP-UHFFFAOYSA-N 1-[2-[(1-benzyl-5-methoxy-2-methylindol-3-yl)methyl-methylamino]ethyl]-n,n-dimethyl-4-phenylpiperidin-4-amine Chemical compound CC1=C(CN(C)CCN2CCC(CC2)(N(C)C)C=2C=CC=CC=2)C2=CC(OC)=CC=C2N1CC1=CC=CC=C1 LYGPZEATHDSVTP-UHFFFAOYSA-N 0.000 claims 2
- KDAPWPPEWBALMZ-UHFFFAOYSA-N 1-[2-[(5-chloro-1h-indol-3-yl)methyl-methylamino]ethyl]-n,n-dimethyl-4-phenylpiperidin-4-amine Chemical compound C=1NC2=CC=C(Cl)C=C2C=1CN(C)CCN(CC1)CCC1(N(C)C)C1=CC=CC=C1 KDAPWPPEWBALMZ-UHFFFAOYSA-N 0.000 claims 2
- ZOUCEMVEMBRLAS-UHFFFAOYSA-N 1-[2-[(5-chloro-1h-indol-3-yl)methylamino]ethyl]-n,n-dimethyl-4-thiophen-2-ylpiperidin-4-amine Chemical compound C1CN(CCNCC=2C3=CC(Cl)=CC=C3NC=2)CCC1(N(C)C)C1=CC=CS1 ZOUCEMVEMBRLAS-UHFFFAOYSA-N 0.000 claims 2
- RYTISKJHIGCPNM-UHFFFAOYSA-N 1-[2-[(5-methoxy-1h-indol-3-yl)methylamino]ethyl]-n,n-dimethyl-4-thiophen-2-ylpiperidin-4-amine Chemical compound C12=CC(OC)=CC=C2NC=C1CNCCN(CC1)CCC1(N(C)C)C1=CC=CS1 RYTISKJHIGCPNM-UHFFFAOYSA-N 0.000 claims 2
- XKPOKDKPDLQOGR-UHFFFAOYSA-N 1-[2-[1h-indol-3-ylmethyl(methyl)amino]ethyl]-n,n-dimethyl-4-phenylpiperidin-4-amine Chemical compound C=1NC2=CC=CC=C2C=1CN(C)CCN(CC1)CCC1(N(C)C)C1=CC=CC=C1 XKPOKDKPDLQOGR-UHFFFAOYSA-N 0.000 claims 2
- VEFZTKZLWLNPEU-UHFFFAOYSA-N 1-[2-[1h-indol-4-ylmethyl(methyl)amino]ethyl]-n,n-dimethyl-4-phenylpiperidin-4-amine Chemical compound C=1C=CC=2NC=CC=2C=1CN(C)CCN(CC1)CCC1(N(C)C)C1=CC=CC=C1 VEFZTKZLWLNPEU-UHFFFAOYSA-N 0.000 claims 2
- ZECNAZWWPHRNLQ-UHFFFAOYSA-N 1-[2-[1h-indol-6-ylmethyl(methyl)amino]ethyl]-n,n-dimethyl-4-phenylpiperidin-4-amine Chemical compound C=1C=C2C=CNC2=CC=1CN(C)CCN(CC1)CCC1(N(C)C)C1=CC=CC=C1 ZECNAZWWPHRNLQ-UHFFFAOYSA-N 0.000 claims 2
- ABFPKTQEQNICFT-UHFFFAOYSA-M 2-chloro-1-methylpyridin-1-ium;iodide Chemical compound [I-].C[N+]1=CC=CC=C1Cl ABFPKTQEQNICFT-UHFFFAOYSA-M 0.000 claims 2
- GLTZHSDOJGAPGU-UHFFFAOYSA-N 6-chloro-n-[2-[4-(dimethylamino)-4-phenylpiperidin-1-yl]ethyl]-n-methyl-2,3,4,9-tetrahydro-1h-carbazole-1-carboxamide Chemical compound C1CN(CCN(C)C(=O)C2C3=C(C4=CC(Cl)=CC=C4N3)CCC2)CCC1(N(C)C)C1=CC=CC=C1 GLTZHSDOJGAPGU-UHFFFAOYSA-N 0.000 claims 2
- 208000007848 Alcoholism Diseases 0.000 claims 2
- 208000024827 Alzheimer disease Diseases 0.000 claims 2
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 claims 2
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 claims 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 claims 2
- JGFZNNIVVJXRND-UHFFFAOYSA-N N,N-Diisopropylethylamine (DIPEA) Chemical compound CCN(C(C)C)C(C)C JGFZNNIVVJXRND-UHFFFAOYSA-N 0.000 claims 2
- KAESVJOAVNADME-UHFFFAOYSA-N Pyrrole Chemical compound C=1C=CNC=1 KAESVJOAVNADME-UHFFFAOYSA-N 0.000 claims 2
- 208000007271 Substance Withdrawal Syndrome Diseases 0.000 claims 2
- DTQVDTLACAAQTR-UHFFFAOYSA-N Trifluoroacetic acid Chemical compound OC(=O)C(F)(F)F DTQVDTLACAAQTR-UHFFFAOYSA-N 0.000 claims 2
- 150000005840 aryl radicals Chemical class 0.000 claims 2
- 230000015572 biosynthetic process Effects 0.000 claims 2
- FJDQFPXHSGXQBY-UHFFFAOYSA-L caesium carbonate Chemical compound [Cs+].[Cs+].[O-]C([O-])=O FJDQFPXHSGXQBY-UHFFFAOYSA-L 0.000 claims 2
- 229910000024 caesium carbonate Inorganic materials 0.000 claims 2
- 229910052799 carbon Inorganic materials 0.000 claims 2
- PFKFTWBEEFSNDU-UHFFFAOYSA-N carbonyldiimidazole Chemical compound C1=CN=CN1C(=O)N1C=CN=C1 PFKFTWBEEFSNDU-UHFFFAOYSA-N 0.000 claims 2
- 150000001768 cations Chemical class 0.000 claims 2
- BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 claims 2
- GUMAMWSSCLCZAB-UHFFFAOYSA-N n,n-dimethyl-1-[2-[methyl-[(6-propan-2-yl-1h-indol-3-yl)methyl]amino]ethyl]-4-phenylpiperidin-4-amine Chemical compound C=1NC2=CC(C(C)C)=CC=C2C=1CN(C)CCN(CC1)CCC1(N(C)C)C1=CC=CC=C1 GUMAMWSSCLCZAB-UHFFFAOYSA-N 0.000 claims 2
- DSFBRRNSTBKUNM-UHFFFAOYSA-N n-[2-[4-(dimethylamino)-4-phenylpiperidin-1-yl]ethyl]-2-(6-fluoro-1h-indol-3-yl)-n-methylacetamide Chemical compound C1CN(CCN(C)C(=O)CC=2C3=CC=C(F)C=C3NC=2)CCC1(N(C)C)C1=CC=CC=C1 DSFBRRNSTBKUNM-UHFFFAOYSA-N 0.000 claims 2
- SXZWTCAYIXJEOS-UHFFFAOYSA-N n-[2-[4-(dimethylamino)-4-phenylpiperidin-1-yl]ethyl]-3-(1h-indol-3-yl)-n,4-dimethylpentanamide Chemical compound C=1NC2=CC=CC=C2C=1C(C(C)C)CC(=O)N(C)CCN(CC1)CCC1(N(C)C)C1=CC=CC=C1 SXZWTCAYIXJEOS-UHFFFAOYSA-N 0.000 claims 2
- OCXWOKQQQRIQKQ-UHFFFAOYSA-N n-[2-[4-(dimethylamino)-4-phenylpiperidin-1-yl]ethyl]-5-fluoro-n-methyl-1h-indole-2-carboxamide Chemical compound C1CN(CCN(C)C(=O)C=2NC3=CC=C(F)C=C3C=2)CCC1(N(C)C)C1=CC=CC=C1 OCXWOKQQQRIQKQ-UHFFFAOYSA-N 0.000 claims 2
- AUKNFZRIIILDET-UHFFFAOYSA-N n-[2-[4-(dimethylamino)-4-phenylpiperidin-1-yl]ethyl]-n-methyl-1h-indole-6-carboxamide Chemical compound C1CN(CCN(C)C(=O)C=2C=C3NC=CC3=CC=2)CCC1(N(C)C)C1=CC=CC=C1 AUKNFZRIIILDET-UHFFFAOYSA-N 0.000 claims 2
- WIZSXFXXNUWCOE-UHFFFAOYSA-N n-[2-[4-(dimethylamino)-4-thiophen-2-ylpiperidin-1-yl]ethyl]-3-(1h-indol-3-yl)-4-methylpentanamide Chemical compound C=1NC2=CC=CC=C2C=1C(C(C)C)CC(=O)NCCN(CC1)CCC1(N(C)C)C1=CC=CS1 WIZSXFXXNUWCOE-UHFFFAOYSA-N 0.000 claims 2
- YEJTVAXRWBWLGQ-UHFFFAOYSA-N n-[2-[4-butyl-4-(dimethylamino)piperidin-1-yl]ethyl]-2-(6-fluoro-1h-indol-3-yl)-n-methylacetamide Chemical compound C1CC(CCCC)(N(C)C)CCN1CCN(C)C(=O)CC1=CNC2=CC(F)=CC=C12 YEJTVAXRWBWLGQ-UHFFFAOYSA-N 0.000 claims 2
- 229910052757 nitrogen Inorganic materials 0.000 claims 2
- 125000004433 nitrogen atom Chemical group N* 0.000 claims 2
- 229940005483 opioid analgesics Drugs 0.000 claims 2
- 239000003960 organic solvent Substances 0.000 claims 2
- 229910000027 potassium carbonate Inorganic materials 0.000 claims 2
- 239000000955 prescription drug Substances 0.000 claims 2
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 claims 2
- 150000003839 salts Chemical class 0.000 claims 2
- 208000011117 substance-related disease Diseases 0.000 claims 2
- 238000006467 substitution reaction Methods 0.000 claims 2
- AQRLNPVMDITEJU-UHFFFAOYSA-N triethylsilane Chemical compound CC[SiH](CC)CC AQRLNPVMDITEJU-UHFFFAOYSA-N 0.000 claims 2
- 125000006552 (C3-C8) cycloalkyl group Chemical group 0.000 claims 1
- SCYULBFZEHDVBN-UHFFFAOYSA-N 1,1-Dichloroethane Chemical compound CC(Cl)Cl SCYULBFZEHDVBN-UHFFFAOYSA-N 0.000 claims 1
- 125000001376 1,2,4-triazolyl group Chemical group N1N=C(N=C1)* 0.000 claims 1
- BPRZKJJPHKRYFH-UHFFFAOYSA-N 1-[2-(1h-indol-3-ylmethylamino)ethyl]-n,n-dimethyl-4-thiophen-2-ylpiperidin-4-amine Chemical compound C1CN(CCNCC=2C3=CC=CC=C3NC=2)CCC1(N(C)C)C1=CC=CS1 BPRZKJJPHKRYFH-UHFFFAOYSA-N 0.000 claims 1
- CLTCEERPDHANHV-UHFFFAOYSA-N 1-[2-(1h-indol-5-ylmethylamino)ethyl]-n,n-dimethyl-4-thiophen-2-ylpiperidin-4-amine Chemical compound C1CN(CCNCC=2C=C3C=CNC3=CC=2)CCC1(N(C)C)C1=CC=CS1 CLTCEERPDHANHV-UHFFFAOYSA-N 0.000 claims 1
- KDDGRKMLSAKHDH-UHFFFAOYSA-N 1-[2-[(1,2-dimethylindol-3-yl)methylamino]ethyl]-n,n-dimethyl-4-thiophen-2-ylpiperidin-4-amine Chemical compound C1CN(CCNCC=2C3=CC=CC=C3N(C)C=2C)CCC1(N(C)C)C1=CC=CS1 KDDGRKMLSAKHDH-UHFFFAOYSA-N 0.000 claims 1
- VHSKKUSQBLXPFP-UHFFFAOYSA-N 1-[2-[(1-benzyl-5-methoxy-2-methylindol-3-yl)methylamino]ethyl]-n,n-dimethyl-4-thiophen-2-ylpiperidin-4-amine Chemical compound CC1=C(CNCCN2CCC(CC2)(N(C)C)C=2SC=CC=2)C2=CC(OC)=CC=C2N1CC1=CC=CC=C1 VHSKKUSQBLXPFP-UHFFFAOYSA-N 0.000 claims 1
- YSGWYMIEOCTQNJ-UHFFFAOYSA-N 1-[2-[(5-bromo-1h-indol-3-yl)methyl-methylamino]ethyl]-4-butyl-n,n-dimethylpiperidin-4-amine Chemical compound C1CC(CCCC)(N(C)C)CCN1CCN(C)CC1=CNC2=CC=C(Br)C=C12 YSGWYMIEOCTQNJ-UHFFFAOYSA-N 0.000 claims 1
- NLMGZWMPAJIATG-UHFFFAOYSA-N 1-[2-[(5-bromo-1h-indol-3-yl)methyl-methylamino]ethyl]-n,n-dimethyl-4-phenylpiperidin-4-amine Chemical compound C=1NC2=CC=C(Br)C=C2C=1CN(C)CCN(CC1)CCC1(N(C)C)C1=CC=CC=C1 NLMGZWMPAJIATG-UHFFFAOYSA-N 0.000 claims 1
- NSGZTYVDEIVMNX-UHFFFAOYSA-N 1-[2-[1h-indol-5-ylmethyl(methyl)amino]ethyl]-n,n-dimethyl-4-phenylpiperidin-4-amine Chemical compound C=1C=C2NC=CC2=CC=1CN(C)CCN(CC1)CCC1(N(C)C)C1=CC=CC=C1 NSGZTYVDEIVMNX-UHFFFAOYSA-N 0.000 claims 1
- ZFMRHHQMBQAHTE-UHFFFAOYSA-N 1-[2-[[2-(4-fluorophenyl)-1h-indol-3-yl]methyl-methylamino]ethyl]-n,n-dimethyl-4-phenylpiperidin-4-amine Chemical compound C=1C=C(F)C=CC=1C=1NC2=CC=CC=C2C=1CN(C)CCN(CC1)CCC1(N(C)C)C1=CC=CC=C1 ZFMRHHQMBQAHTE-UHFFFAOYSA-N 0.000 claims 1
- ZKIJPVQJIMGDAN-UHFFFAOYSA-N 1-[3-[(1,2-dimethylindol-3-yl)methyl-methylamino]propyl]-n,n-dimethyl-4-thiophen-2-ylpiperidin-4-amine Chemical compound CC=1N(C)C2=CC=CC=C2C=1CN(C)CCCN(CC1)CCC1(N(C)C)C1=CC=CS1 ZKIJPVQJIMGDAN-UHFFFAOYSA-N 0.000 claims 1
- NFDSQBOAENBSFZ-UHFFFAOYSA-N 1-[3-[4-(dimethylamino)-4-phenylpiperidine-1-carbonyl]-2,3-dihydroindol-1-yl]-2-(6-fluoro-1h-indol-3-yl)ethanone Chemical compound C1CN(C(=O)C2C3=CC=CC=C3N(C(=O)CC=3C4=CC=C(F)C=C4NC=3)C2)CCC1(N(C)C)C1=CC=CC=C1 NFDSQBOAENBSFZ-UHFFFAOYSA-N 0.000 claims 1
- YKONAAJIUWYMAA-UHFFFAOYSA-N 1-[3-[4-(dimethylamino)-4-phenylpiperidine-1-carbonyl]-2,3-dihydroindol-1-yl]-3-(1h-indol-3-yl)-4-methylpentan-1-one Chemical compound C=1NC2=CC=CC=C2C=1C(C(C)C)CC(=O)N(C1=CC=CC=C11)CC1C(=O)N(CC1)CCC1(N(C)C)C1=CC=CC=C1 YKONAAJIUWYMAA-UHFFFAOYSA-N 0.000 claims 1
- KKQBXQPXCKGZNZ-UHFFFAOYSA-N 1-[3-[4-(dimethylamino)-4-phenylpiperidine-1-carbonyl]piperidin-1-yl]-2-(6-fluoro-1h-indol-3-yl)ethanone Chemical compound C1CN(C(=O)C2CN(CCC2)C(=O)CC=2C3=CC=C(F)C=C3NC=2)CCC1(N(C)C)C1=CC=CC=C1 KKQBXQPXCKGZNZ-UHFFFAOYSA-N 0.000 claims 1
- ZWUSTCHZAHKNKU-UHFFFAOYSA-N 1-[3-[4-(dimethylamino)-4-phenylpiperidine-1-carbonyl]piperidin-1-yl]-3-(1-methylindol-3-yl)propan-1-one Chemical compound C1CN(C(=O)C2CN(CCC2)C(=O)CCC=2C3=CC=CC=C3N(C)C=2)CCC1(N(C)C)C1=CC=CC=C1 ZWUSTCHZAHKNKU-UHFFFAOYSA-N 0.000 claims 1
- HJSBDIRAQGXBDE-UHFFFAOYSA-N 1-[3-[4-(dimethylamino)-4-phenylpiperidine-1-carbonyl]piperidin-1-yl]-3-(1h-indol-3-yl)-4-methylpentan-1-one Chemical compound C=1NC2=CC=CC=C2C=1C(C(C)C)CC(=O)N(C1)CCCC1C(=O)N(CC1)CCC1(N(C)C)C1=CC=CC=C1 HJSBDIRAQGXBDE-UHFFFAOYSA-N 0.000 claims 1
- ZZUDSUMWCDCZGQ-UHFFFAOYSA-N 1-[3-[4-(dimethylamino)-4-phenylpiperidine-1-carbonyl]piperidin-1-yl]-3-(1h-indol-3-yl)butan-1-one Chemical compound C=1NC2=CC=CC=C2C=1C(C)CC(=O)N(C1)CCCC1C(=O)N(CC1)CCC1(N(C)C)C1=CC=CC=C1 ZZUDSUMWCDCZGQ-UHFFFAOYSA-N 0.000 claims 1
- SPGUYVPEXLSAJM-UHFFFAOYSA-N 1-[3-[4-(dimethylamino)-4-phenylpiperidine-1-carbonyl]piperidin-1-yl]-3-(1h-indol-3-yl)propan-1-one Chemical compound C1CN(C(=O)C2CN(CCC2)C(=O)CCC=2C3=CC=CC=C3NC=2)CCC1(N(C)C)C1=CC=CC=C1 SPGUYVPEXLSAJM-UHFFFAOYSA-N 0.000 claims 1
- FQXOBOSLXVTBSY-UHFFFAOYSA-N 1-[4-(dimethylamino)-4-phenylpiperidin-1-yl]-2-[1h-indol-5-ylmethyl(methyl)amino]-3-methylbutan-1-one Chemical compound C=1C=C2NC=CC2=CC=1CN(C)C(C(C)C)C(=O)N(CC1)CCC1(N(C)C)C1=CC=CC=C1 FQXOBOSLXVTBSY-UHFFFAOYSA-N 0.000 claims 1
- CMLQUCODDTWZDU-UHFFFAOYSA-N 1-[4-(dimethylamino)-4-phenylpiperidin-1-yl]-3-(1h-indol-3-ylmethylamino)propan-1-one Chemical compound C1CN(C(=O)CCNCC=2C3=CC=CC=C3NC=2)CCC1(N(C)C)C1=CC=CC=C1 CMLQUCODDTWZDU-UHFFFAOYSA-N 0.000 claims 1
- LWFZHTTWEMCKBU-UHFFFAOYSA-N 1-[4-(dimethylamino)-4-phenylpiperidin-1-yl]-3-(1h-indol-5-ylmethylamino)propan-1-one Chemical compound C1CN(C(=O)CCNCC=2C=C3C=CNC3=CC=2)CCC1(N(C)C)C1=CC=CC=C1 LWFZHTTWEMCKBU-UHFFFAOYSA-N 0.000 claims 1
- JNUGYWAMGKYHBT-UHFFFAOYSA-N 1-[4-(dimethylamino)-4-phenylpiperidin-1-yl]-3-(1h-indol-6-ylmethylamino)propan-1-one Chemical compound C1CN(C(=O)CCNCC=2C=C3NC=CC3=CC=2)CCC1(N(C)C)C1=CC=CC=C1 JNUGYWAMGKYHBT-UHFFFAOYSA-N 0.000 claims 1
- OTGSTEWKYINAAQ-UHFFFAOYSA-N 1-[4-(dimethylamino)-4-phenylpiperidin-1-yl]-3-(1h-indol-7-ylmethylamino)propan-1-one Chemical compound C1CN(C(=O)CCNCC=2C=3NC=CC=3C=CC=2)CCC1(N(C)C)C1=CC=CC=C1 OTGSTEWKYINAAQ-UHFFFAOYSA-N 0.000 claims 1
- AUZDCMPSSRJRCO-UHFFFAOYSA-N 1-[4-(dimethylamino)-4-phenylpiperidin-1-yl]-3-[(2-methyl-1h-indol-3-yl)methylamino]propan-1-one Chemical compound C1CN(C(=O)CCNCC=2C3=CC=CC=C3NC=2C)CCC1(N(C)C)C1=CC=CC=C1 AUZDCMPSSRJRCO-UHFFFAOYSA-N 0.000 claims 1
- HLEFKMDOGCEYPG-UHFFFAOYSA-N 1-[4-(dimethylamino)-4-thiophen-2-ylpiperidin-1-yl]-2-(1h-indol-7-ylmethylamino)ethanone Chemical compound C1CN(C(=O)CNCC=2C=3NC=CC=3C=CC=2)CCC1(N(C)C)C1=CC=CS1 HLEFKMDOGCEYPG-UHFFFAOYSA-N 0.000 claims 1
- JQJZLNSSBKQOHA-UHFFFAOYSA-N 1-[4-(dimethylamino)-4-thiophen-2-ylpiperidin-1-yl]-2-[1h-indol-5-ylmethyl(methyl)amino]-2-phenylethanone Chemical compound C=1C=C2NC=CC2=CC=1CN(C)C(C=1C=CC=CC=1)C(=O)N(CC1)CCC1(N(C)C)C1=CC=CS1 JQJZLNSSBKQOHA-UHFFFAOYSA-N 0.000 claims 1
- ALTLNTCEEWXHFM-UHFFFAOYSA-N 1-[4-(dimethylamino)-4-thiophen-2-ylpiperidin-1-yl]-2-[1h-indol-6-ylmethyl(methyl)amino]-2-phenylethanone Chemical compound C=1C=C2C=CNC2=CC=1CN(C)C(C=1C=CC=CC=1)C(=O)N(CC1)CCC1(N(C)C)C1=CC=CS1 ALTLNTCEEWXHFM-UHFFFAOYSA-N 0.000 claims 1
- VAOHLWNZGWBTOK-UHFFFAOYSA-N 1-[4-(dimethylamino)-4-thiophen-2-ylpiperidin-1-yl]-3-(1h-indol-3-ylmethylamino)-3-phenylpropan-1-one Chemical compound C1CC(N(C)C)(C=2SC=CC=2)CCN1C(=O)CC(NCC=1C2=CC=CC=C2NC=1)C1=CC=CC=C1 VAOHLWNZGWBTOK-UHFFFAOYSA-N 0.000 claims 1
- JQCGTOPHNOILMA-UHFFFAOYSA-N 1-[4-(dimethylamino)-4-thiophen-2-ylpiperidin-1-yl]-3-(1h-indol-4-ylmethylamino)-3-phenylpropan-1-one Chemical compound C1CC(N(C)C)(C=2SC=CC=2)CCN1C(=O)CC(NCC=1C=2C=CNC=2C=CC=1)C1=CC=CC=C1 JQCGTOPHNOILMA-UHFFFAOYSA-N 0.000 claims 1
- BQTPPLVLVUXUAO-UHFFFAOYSA-N 1-[4-(dimethylamino)-4-thiophen-2-ylpiperidin-1-yl]-3-(1h-indol-5-ylmethylamino)-3-phenylpropan-1-one Chemical compound C1CC(N(C)C)(C=2SC=CC=2)CCN1C(=O)CC(NCC=1C=C2C=CNC2=CC=1)C1=CC=CC=C1 BQTPPLVLVUXUAO-UHFFFAOYSA-N 0.000 claims 1
- NGSDKBRWYABHLJ-UHFFFAOYSA-N 1-[4-(dimethylamino)-4-thiophen-2-ylpiperidin-1-yl]-3-(1h-indol-6-ylmethylamino)-3-phenylpropan-1-one Chemical compound C1CC(N(C)C)(C=2SC=CC=2)CCN1C(=O)CC(NCC=1C=C2NC=CC2=CC=1)C1=CC=CC=C1 NGSDKBRWYABHLJ-UHFFFAOYSA-N 0.000 claims 1
- JEPBJURQHYMQRJ-UHFFFAOYSA-N 1-[4-(dimethylamino)-4-thiophen-2-ylpiperidin-1-yl]-3-(1h-indol-7-ylmethylamino)-3-phenylpropan-1-one Chemical compound C1CC(N(C)C)(C=2SC=CC=2)CCN1C(=O)CC(NCC=1C=2NC=CC=2C=CC=1)C1=CC=CC=C1 JEPBJURQHYMQRJ-UHFFFAOYSA-N 0.000 claims 1
- LMDZBCPBFSXMTL-UHFFFAOYSA-N 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide Chemical compound CCN=C=NCCCN(C)C LMDZBCPBFSXMTL-UHFFFAOYSA-N 0.000 claims 1
- FEQWGDUFHRTVAV-UHFFFAOYSA-N 2-(5-bromo-1h-indol-3-yl)-1-[3-[4-(dimethylamino)-4-phenylpiperidine-1-carbonyl]piperidin-1-yl]ethanone Chemical compound C1CN(C(=O)C2CN(CCC2)C(=O)CC=2C3=CC(Br)=CC=C3NC=2)CCC1(N(C)C)C1=CC=CC=C1 FEQWGDUFHRTVAV-UHFFFAOYSA-N 0.000 claims 1
- YVVSBJJLDVHWOP-UHFFFAOYSA-N 2-(5-bromo-1h-indol-3-yl)-n-[1-[4-(dimethylamino)-4-phenylpiperidin-1-yl]-3-methyl-1-oxobutan-2-yl]-n-methylacetamide Chemical compound C=1NC2=CC=C(Br)C=C2C=1CC(=O)N(C)C(C(C)C)C(=O)N(CC1)CCC1(N(C)C)C1=CC=CC=C1 YVVSBJJLDVHWOP-UHFFFAOYSA-N 0.000 claims 1
- RKTAVFFBVGTPFO-UHFFFAOYSA-N 2-(5-bromo-1h-indol-3-yl)-n-[2-[4-(dimethylamino)-4-thiophen-2-ylpiperidin-1-yl]-2-oxo-1-phenylethyl]-n-methylacetamide Chemical compound C1CC(N(C)C)(C=2SC=CC=2)CCN1C(=O)C(N(C)C(=O)CC=1C2=CC(Br)=CC=C2NC=1)C1=CC=CC=C1 RKTAVFFBVGTPFO-UHFFFAOYSA-N 0.000 claims 1
- ONIKNECPXCLUHT-UHFFFAOYSA-N 2-chlorobenzoyl chloride Chemical compound ClC(=O)C1=CC=CC=C1Cl ONIKNECPXCLUHT-UHFFFAOYSA-N 0.000 claims 1
- 125000000094 2-phenylethyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])C([H])([H])* 0.000 claims 1
- 125000003903 2-propenyl group Chemical group [H]C([*])([H])C([H])=C([H])[H] 0.000 claims 1
- FPQQSJJWHUJYPU-UHFFFAOYSA-N 3-(dimethylamino)propyliminomethylidene-ethylazanium;chloride Chemical compound Cl.CCN=C=NCCCN(C)C FPQQSJJWHUJYPU-UHFFFAOYSA-N 0.000 claims 1
- OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 claims 1
- VHYFNPMBLIVWCW-UHFFFAOYSA-N 4-Dimethylaminopyridine Chemical compound CN(C)C1=CC=NC=C1 VHYFNPMBLIVWCW-UHFFFAOYSA-N 0.000 claims 1
- OIGJFFBFVWAOQF-UHFFFAOYSA-N 4-butyl-1-[2-[1h-indol-3-ylmethyl(methyl)amino]ethyl]-n,n-dimethylpiperidin-4-amine Chemical compound C1CC(CCCC)(N(C)C)CCN1CCN(C)CC1=CNC2=CC=CC=C12 OIGJFFBFVWAOQF-UHFFFAOYSA-N 0.000 claims 1
- KKGAVFRTLHYQQY-UHFFFAOYSA-N 4-butyl-1-[2-[1h-indol-4-ylmethyl(methyl)amino]ethyl]-n,n-dimethylpiperidin-4-amine Chemical compound C1CC(CCCC)(N(C)C)CCN1CCN(C)CC1=CC=CC2=C1C=CN2 KKGAVFRTLHYQQY-UHFFFAOYSA-N 0.000 claims 1
- XUTWLQPWQKMMPT-UHFFFAOYSA-N 4-butyl-1-[2-[1h-indol-5-ylmethyl(methyl)amino]ethyl]-n,n-dimethylpiperidin-4-amine Chemical compound C1CC(CCCC)(N(C)C)CCN1CCN(C)CC1=CC=C(NC=C2)C2=C1 XUTWLQPWQKMMPT-UHFFFAOYSA-N 0.000 claims 1
- UUPIYCXVMFYPIB-UHFFFAOYSA-N 4-butyl-1-[2-[1h-indol-6-ylmethyl(methyl)amino]ethyl]-n,n-dimethylpiperidin-4-amine Chemical compound C1CC(CCCC)(N(C)C)CCN1CCN(C)CC1=CC=C(C=CN2)C2=C1 UUPIYCXVMFYPIB-UHFFFAOYSA-N 0.000 claims 1
- VACZJZGEJIAJDM-UHFFFAOYSA-N 4-butyl-1-[2-[1h-indol-7-ylmethyl(methyl)amino]ethyl]-n,n-dimethylpiperidin-4-amine Chemical compound C1CC(CCCC)(N(C)C)CCN1CCN(C)CC1=CC=CC2=C1NC=C2 VACZJZGEJIAJDM-UHFFFAOYSA-N 0.000 claims 1
- LRDCMDKEJNRFAP-UHFFFAOYSA-N 5-fluoro-n-methyl-n-[2-(4-phenyl-4-pyrrolidin-1-ylpiperidin-1-yl)ethyl]-1h-indole-2-carboxamide Chemical compound C=1C2=CC(F)=CC=C2NC=1C(=O)N(C)CCN(CC1)CCC1(C=1C=CC=CC=1)N1CCCC1 LRDCMDKEJNRFAP-UHFFFAOYSA-N 0.000 claims 1
- CSYUSWFKMPDNHA-UHFFFAOYSA-N 5-methoxy-n-methyl-n-[2-(4-phenyl-4-pyrrolidin-1-ylpiperidin-1-yl)ethyl]-1h-indole-2-carboxamide Chemical compound C=1C2=CC(OC)=CC=C2NC=1C(=O)N(C)CCN(CC1)CCC1(C=1C=CC=CC=1)N1CCCC1 CSYUSWFKMPDNHA-UHFFFAOYSA-N 0.000 claims 1
- JRVZKDNDWBJNGG-UHFFFAOYSA-N 6-(dimethylamino)-n-[3-[4-(dimethylamino)-4-phenylpiperidin-1-yl]-3-oxopropyl]-1h-indole-2-carboxamide Chemical compound N1C2=CC(N(C)C)=CC=C2C=C1C(=O)NCCC(=O)N(CC1)CCC1(N(C)C)C1=CC=CC=C1 JRVZKDNDWBJNGG-UHFFFAOYSA-N 0.000 claims 1
- RFCJPBAODMJWMN-UHFFFAOYSA-N 6-chloro-n-[2-[4-(dimethylamino)-4-thiophen-2-ylpiperidin-1-yl]-2-oxo-1-phenylethyl]-n-methyl-2,3,4,9-tetrahydro-1h-carbazole-1-carboxamide Chemical compound C1CC(N(C)C)(C=2SC=CC=2)CCN1C(=O)C(N(C)C(=O)C1C2=C(C3=CC(Cl)=CC=C3N2)CCC1)C1=CC=CC=C1 RFCJPBAODMJWMN-UHFFFAOYSA-N 0.000 claims 1
- WPBBIGOJMRHATB-UHFFFAOYSA-N 6-chloro-n-[2-[4-(dimethylamino)-4-thiophen-2-ylpiperidin-1-yl]-2-oxoethyl]-2,3,4,9-tetrahydro-1h-carbazole-1-carboxamide Chemical compound C1CN(C(=O)CNC(=O)C2C3=C(C4=CC(Cl)=CC=C4N3)CCC2)CCC1(N(C)C)C1=CC=CS1 WPBBIGOJMRHATB-UHFFFAOYSA-N 0.000 claims 1
- QWIDTDGIUZUSAV-UHFFFAOYSA-N 6-chloro-n-[2-[4-(dimethylamino)-4-thiophen-2-ylpiperidin-1-yl]ethyl]-2,3,4,9-tetrahydro-1h-carbazole-1-carboxamide Chemical compound C1CN(CCNC(=O)C2C3=C(C4=CC(Cl)=CC=C4N3)CCC2)CCC1(N(C)C)C1=CC=CS1 QWIDTDGIUZUSAV-UHFFFAOYSA-N 0.000 claims 1
- FLEQQRZULRUEJL-UHFFFAOYSA-N 6-chloro-n-[3-[4-(dimethylamino)-4-phenylpiperidin-1-yl]-3-oxopropyl]-2,3,4,9-tetrahydro-1h-carbazole-1-carboxamide Chemical compound C1CN(C(=O)CCNC(=O)C2C3=C(C4=CC(Cl)=CC=C4N3)CCC2)CCC1(N(C)C)C1=CC=CC=C1 FLEQQRZULRUEJL-UHFFFAOYSA-N 0.000 claims 1
- IEBIASOFAJZGHQ-UHFFFAOYSA-N 6-chloro-n-[3-[4-(dimethylamino)-4-phenylpiperidin-1-yl]propyl]-n-methyl-2,3,4,9-tetrahydro-1h-carbazole-1-carboxamide Chemical compound C1CN(CCCN(C)C(=O)C2C3=C(C4=CC(Cl)=CC=C4N3)CCC2)CCC1(N(C)C)C1=CC=CC=C1 IEBIASOFAJZGHQ-UHFFFAOYSA-N 0.000 claims 1
- NEKIRBYWRRMNCU-UHFFFAOYSA-N 6-chloro-n-methyl-n-[2-(4-phenyl-4-pyrrolidin-1-ylpiperidin-1-yl)ethyl]-2,3,4,9-tetrahydro-1h-carbazole-1-carboxamide Chemical compound C1CCC(C2=CC(Cl)=CC=C2N2)=C2C1C(=O)N(C)CCN(CC1)CCC1(C=1C=CC=CC=1)N1CCCC1 NEKIRBYWRRMNCU-UHFFFAOYSA-N 0.000 claims 1
- 208000019901 Anxiety disease Diseases 0.000 claims 1
- 206010006895 Cachexia Diseases 0.000 claims 1
- 208000024172 Cardiovascular disease Diseases 0.000 claims 1
- 208000000094 Chronic Pain Diseases 0.000 claims 1
- 206010012335 Dependence Diseases 0.000 claims 1
- 206010012735 Diarrhoea Diseases 0.000 claims 1
- 206010013654 Drug abuse Diseases 0.000 claims 1
- 208000017228 Gastrointestinal motility disease Diseases 0.000 claims 1
- 206010020772 Hypertension Diseases 0.000 claims 1
- 208000001953 Hypotension Diseases 0.000 claims 1
- 208000019695 Migraine disease Diseases 0.000 claims 1
- 208000023178 Musculoskeletal disease Diseases 0.000 claims 1
- 102100028646 Nociceptin receptor Human genes 0.000 claims 1
- 208000008589 Obesity Diseases 0.000 claims 1
- 208000004880 Polyuria Diseases 0.000 claims 1
- YZCKVEUIGOORGS-IGMARMGPSA-N Protium Chemical compound [1H] YZCKVEUIGOORGS-IGMARMGPSA-N 0.000 claims 1
- 208000003251 Pruritus Diseases 0.000 claims 1
- 206010039966 Senile dementia Diseases 0.000 claims 1
- 201000001880 Sexual dysfunction Diseases 0.000 claims 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 claims 1
- 239000012317 TBTU Substances 0.000 claims 1
- 208000009205 Tinnitus Diseases 0.000 claims 1
- 206010046543 Urinary incontinence Diseases 0.000 claims 1
- 206010048010 Withdrawal syndrome Diseases 0.000 claims 1
- PJEDENZBTNGQNG-UHFFFAOYSA-N [1-(6-chloro-2,3,4,9-tetrahydro-1h-carbazole-1-carbonyl)piperidin-3-yl]-[4-(dimethylamino)-4-phenylpiperidin-1-yl]methanone Chemical compound C1CN(C(=O)C2CN(CCC2)C(=O)C2C3=C(C4=CC(Cl)=CC=C4N3)CCC2)CCC1(N(C)C)C1=CC=CC=C1 PJEDENZBTNGQNG-UHFFFAOYSA-N 0.000 claims 1
- NVOGFRXWGAVSLM-UHFFFAOYSA-N [1-[(5-bromo-1h-indol-3-yl)methyl]piperidin-3-yl]-[4-(dimethylamino)-4-phenylpiperidin-1-yl]methanone Chemical compound C1CN(C(=O)C2CN(CC=3C4=CC(Br)=CC=C4NC=3)CCC2)CCC1(N(C)C)C1=CC=CC=C1 NVOGFRXWGAVSLM-UHFFFAOYSA-N 0.000 claims 1
- XWUXKOBUMKZCOA-UHFFFAOYSA-N [1-[6-(dimethylamino)-1h-indole-2-carbonyl]piperidin-3-yl]-[4-(dimethylamino)-4-phenylpiperidin-1-yl]methanone Chemical compound N1C2=CC(N(C)C)=CC=C2C=C1C(=O)N(C1)CCCC1C(=O)N(CC1)CCC1(N(C)C)C1=CC=CC=C1 XWUXKOBUMKZCOA-UHFFFAOYSA-N 0.000 claims 1
- KATXFFKQRFCEBH-UHFFFAOYSA-N [4-(dimethylamino)-4-phenylpiperidin-1-yl]-[1-(1-methylindole-4-carbonyl)piperidin-3-yl]methanone Chemical compound C1CN(C(=O)C2CN(CCC2)C(=O)C=2C=3C=CN(C)C=3C=CC=2)CCC1(N(C)C)C1=CC=CC=C1 KATXFFKQRFCEBH-UHFFFAOYSA-N 0.000 claims 1
- WSDPDZXYGSQUTC-UHFFFAOYSA-N [4-(dimethylamino)-4-phenylpiperidin-1-yl]-[1-(1-methylindole-6-carbonyl)-2,3-dihydroindol-3-yl]methanone Chemical compound C1CN(C(=O)C2C3=CC=CC=C3N(C(=O)C=3C=C4N(C)C=CC4=CC=3)C2)CCC1(N(C)C)C1=CC=CC=C1 WSDPDZXYGSQUTC-UHFFFAOYSA-N 0.000 claims 1
- RXNZLPGBMMQLRF-UHFFFAOYSA-N [4-(dimethylamino)-4-phenylpiperidin-1-yl]-[1-(1-methylindole-6-carbonyl)piperidin-3-yl]methanone Chemical compound C1CN(C(=O)C2CN(CCC2)C(=O)C=2C=C3N(C)C=CC3=CC=2)CCC1(N(C)C)C1=CC=CC=C1 RXNZLPGBMMQLRF-UHFFFAOYSA-N 0.000 claims 1
- HMJLHRJJUCXXKE-UHFFFAOYSA-N [4-(dimethylamino)-4-phenylpiperidin-1-yl]-[1-(1h-indol-3-ylmethyl)piperidin-3-yl]methanone Chemical compound C1CN(C(=O)C2CN(CC=3C4=CC=CC=C4NC=3)CCC2)CCC1(N(C)C)C1=CC=CC=C1 HMJLHRJJUCXXKE-UHFFFAOYSA-N 0.000 claims 1
- RRQWPNAJLOBZFS-UHFFFAOYSA-N [4-(dimethylamino)-4-phenylpiperidin-1-yl]-[1-(1h-indol-4-ylmethyl)-2,3-dihydroindol-3-yl]methanone Chemical compound C1CN(C(=O)C2C3=CC=CC=C3N(CC=3C=4C=CNC=4C=CC=3)C2)CCC1(N(C)C)C1=CC=CC=C1 RRQWPNAJLOBZFS-UHFFFAOYSA-N 0.000 claims 1
- YVHLILKGLMMUJH-UHFFFAOYSA-N [4-(dimethylamino)-4-phenylpiperidin-1-yl]-[1-(1h-indol-4-ylmethyl)piperidin-3-yl]methanone Chemical compound C1CN(C(=O)C2CN(CC=3C=4C=CNC=4C=CC=3)CCC2)CCC1(N(C)C)C1=CC=CC=C1 YVHLILKGLMMUJH-UHFFFAOYSA-N 0.000 claims 1
- GFHQKOAVSRDWOG-UHFFFAOYSA-N [4-(dimethylamino)-4-phenylpiperidin-1-yl]-[1-(1h-indol-5-ylmethyl)-2,3-dihydroindol-3-yl]methanone Chemical compound C1CN(C(=O)C2C3=CC=CC=C3N(CC=3C=C4C=CNC4=CC=3)C2)CCC1(N(C)C)C1=CC=CC=C1 GFHQKOAVSRDWOG-UHFFFAOYSA-N 0.000 claims 1
- IYIPJVXPVODFNE-UHFFFAOYSA-N [4-(dimethylamino)-4-phenylpiperidin-1-yl]-[1-(1h-indol-5-ylmethyl)piperidin-3-yl]methanone Chemical compound C1CN(C(=O)C2CN(CC=3C=C4C=CNC4=CC=3)CCC2)CCC1(N(C)C)C1=CC=CC=C1 IYIPJVXPVODFNE-UHFFFAOYSA-N 0.000 claims 1
- BEAUTPUCMHLZOU-UHFFFAOYSA-N [4-(dimethylamino)-4-phenylpiperidin-1-yl]-[1-(1h-indol-6-ylmethyl)-2,3-dihydroindol-3-yl]methanone Chemical compound C1CN(C(=O)C2C3=CC=CC=C3N(CC=3C=C4NC=CC4=CC=3)C2)CCC1(N(C)C)C1=CC=CC=C1 BEAUTPUCMHLZOU-UHFFFAOYSA-N 0.000 claims 1
- RGYHXUSEJNQGNH-UHFFFAOYSA-N [4-(dimethylamino)-4-phenylpiperidin-1-yl]-[1-(1h-indol-6-ylmethyl)piperidin-3-yl]methanone Chemical compound C1CN(C(=O)C2CN(CC=3C=C4NC=CC4=CC=3)CCC2)CCC1(N(C)C)C1=CC=CC=C1 RGYHXUSEJNQGNH-UHFFFAOYSA-N 0.000 claims 1
- HRUHMEILUDYGEE-UHFFFAOYSA-N [4-(dimethylamino)-4-phenylpiperidin-1-yl]-[1-(1h-indol-7-ylmethyl)piperidin-3-yl]methanone Chemical compound C1CN(C(=O)C2CN(CC=3C=4NC=CC=4C=CC=3)CCC2)CCC1(N(C)C)C1=CC=CC=C1 HRUHMEILUDYGEE-UHFFFAOYSA-N 0.000 claims 1
- YMPDVNSPZVKEPM-UHFFFAOYSA-N [4-(dimethylamino)-4-phenylpiperidin-1-yl]-[1-(1h-indole-3-carbonyl)piperidin-3-yl]methanone Chemical compound C1CN(C(=O)C2CN(CCC2)C(=O)C=2C3=CC=CC=C3NC=2)CCC1(N(C)C)C1=CC=CC=C1 YMPDVNSPZVKEPM-UHFFFAOYSA-N 0.000 claims 1
- SOZRBQJOENTOFF-UHFFFAOYSA-N [4-(dimethylamino)-4-phenylpiperidin-1-yl]-[1-(1h-indole-6-carbonyl)piperidin-3-yl]methanone Chemical compound C1CN(C(=O)C2CN(CCC2)C(=O)C=2C=C3NC=CC3=CC=2)CCC1(N(C)C)C1=CC=CC=C1 SOZRBQJOENTOFF-UHFFFAOYSA-N 0.000 claims 1
- SIRVUXCRPLVHSJ-UHFFFAOYSA-N [4-(dimethylamino)-4-phenylpiperidin-1-yl]-[1-(5-fluoro-1h-indole-2-carbonyl)piperidin-3-yl]methanone Chemical compound C1CN(C(=O)C2CN(CCC2)C(=O)C=2NC3=CC=C(F)C=C3C=2)CCC1(N(C)C)C1=CC=CC=C1 SIRVUXCRPLVHSJ-UHFFFAOYSA-N 0.000 claims 1
- IIEXSAAGCXUIFG-UHFFFAOYSA-N [4-(dimethylamino)-4-phenylpiperidin-1-yl]-[1-[(2-methyl-1h-indol-3-yl)methyl]piperidin-3-yl]methanone Chemical compound C1CN(C(=O)C2CN(CC=3C4=CC=CC=C4NC=3C)CCC2)CCC1(N(C)C)C1=CC=CC=C1 IIEXSAAGCXUIFG-UHFFFAOYSA-N 0.000 claims 1
- UINDZYKBRQCYQQ-UHFFFAOYSA-N [4-(dimethylamino)-4-phenylpiperidin-1-yl]-[1-[(6-methoxy-1,2-dimethylindol-3-yl)methyl]piperidin-3-yl]methanone Chemical compound CC=1N(C)C2=CC(OC)=CC=C2C=1CN(C1)CCCC1C(=O)N(CC1)CCC1(N(C)C)C1=CC=CC=C1 UINDZYKBRQCYQQ-UHFFFAOYSA-N 0.000 claims 1
- LNQHKTJCGPTIOK-UHFFFAOYSA-N [4-(dimethylamino)-4-phenylpiperidin-1-yl]-[1-[[2-(4-fluorophenyl)-1h-indol-3-yl]methyl]piperidin-3-yl]methanone Chemical compound C1CC(N(C)C)(C=2C=CC=CC=2)CCN1C(=O)C(C1)CCCN1CC(C1=CC=CC=C1N1)=C1C1=CC=C(F)C=C1 LNQHKTJCGPTIOK-UHFFFAOYSA-N 0.000 claims 1
- CIUQDSCDWFSTQR-UHFFFAOYSA-N [C]1=CC=CC=C1 Chemical compound [C]1=CC=CC=C1 CIUQDSCDWFSTQR-UHFFFAOYSA-N 0.000 claims 1
- CLZISMQKJZCZDN-UHFFFAOYSA-N [benzotriazol-1-yloxy(dimethylamino)methylidene]-dimethylazanium Chemical compound C1=CC=C2N(OC(N(C)C)=[N+](C)C)N=NC2=C1 CLZISMQKJZCZDN-UHFFFAOYSA-N 0.000 claims 1
- 230000001154 acute effect Effects 0.000 claims 1
- 208000005298 acute pain Diseases 0.000 claims 1
- 206010001584 alcohol abuse Diseases 0.000 claims 1
- 201000007930 alcohol dependence Diseases 0.000 claims 1
- 208000025746 alcohol use disease Diseases 0.000 claims 1
- 150000001299 aldehydes Chemical class 0.000 claims 1
- 230000003444 anaesthetic effect Effects 0.000 claims 1
- 230000000202 analgesic effect Effects 0.000 claims 1
- 208000022531 anorexia Diseases 0.000 claims 1
- 230000001773 anti-convulsant effect Effects 0.000 claims 1
- 239000001961 anticonvulsive agent Substances 0.000 claims 1
- 229960003965 antiepileptics Drugs 0.000 claims 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 claims 1
- 125000003785 benzimidazolyl group Chemical group N1=C(NC2=C1C=CC=C2)* 0.000 claims 1
- 125000002619 bicyclic group Chemical group 0.000 claims 1
- 239000011230 binding agent Substances 0.000 claims 1
- NNTOJPXOCKCMKR-UHFFFAOYSA-N boron;pyridine Chemical compound [B].C1=CC=NC=C1 NNTOJPXOCKCMKR-UHFFFAOYSA-N 0.000 claims 1
- DNSISZSEWVHGLH-UHFFFAOYSA-N butanamide Chemical compound CCCC(N)=O DNSISZSEWVHGLH-UHFFFAOYSA-N 0.000 claims 1
- 229910000019 calcium carbonate Inorganic materials 0.000 claims 1
- 125000002837 carbocyclic group Chemical group 0.000 claims 1
- 239000003638 chemical reducing agent Substances 0.000 claims 1
- 238000011260 co-administration Methods 0.000 claims 1
- 208000010877 cognitive disease Diseases 0.000 claims 1
- 125000004122 cyclic group Chemical group 0.000 claims 1
- 125000000753 cycloalkyl group Chemical group 0.000 claims 1
- 206010061428 decreased appetite Diseases 0.000 claims 1
- 125000002147 dimethylamino group Chemical group [H]C([H])([H])N(*)C([H])([H])[H] 0.000 claims 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 1
- 208000035475 disorder Diseases 0.000 claims 1
- 230000035619 diuresis Effects 0.000 claims 1
- 229940079593 drug Drugs 0.000 claims 1
- 206010013663 drug dependence Diseases 0.000 claims 1
- 206010015037 epilepsy Diseases 0.000 claims 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 claims 1
- 230000037406 food intake Effects 0.000 claims 1
- 235000012631 food intake Nutrition 0.000 claims 1
- 235000019253 formic acid Nutrition 0.000 claims 1
- 208000016354 hearing loss disease Diseases 0.000 claims 1
- 229910052739 hydrogen Inorganic materials 0.000 claims 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 claims 1
- 230000036543 hypotension Effects 0.000 claims 1
- 125000002883 imidazolyl group Chemical group 0.000 claims 1
- 150000007529 inorganic bases Chemical class 0.000 claims 1
- 125000000959 isobutyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])* 0.000 claims 1
- 125000001972 isopentyl group Chemical group [H]C([H])([H])C([H])(C([H])([H])[H])C([H])([H])C([H])([H])* 0.000 claims 1
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 claims 1
- 230000007803 itching Effects 0.000 claims 1
- 201000003723 learning disability Diseases 0.000 claims 1
- 230000006742 locomotor activity Effects 0.000 claims 1
- WSFSSNUMVMOOMR-BJUDXGSMSA-N methanone Chemical compound O=[11CH2] WSFSSNUMVMOOMR-BJUDXGSMSA-N 0.000 claims 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims 1
- 206010027599 migraine Diseases 0.000 claims 1
- 102000051367 mu Opioid Receptors Human genes 0.000 claims 1
- 239000003158 myorelaxant agent Substances 0.000 claims 1
- HPALGCLEZMFERL-UHFFFAOYSA-N n,1-dimethyl-n-[2-(4-phenyl-4-pyrrolidin-1-ylpiperidin-1-yl)ethyl]indole-4-carboxamide Chemical compound C=1C=CC=2N(C)C=CC=2C=1C(=O)N(C)CCN(CC1)CCC1(C=1C=CC=CC=1)N1CCCC1 HPALGCLEZMFERL-UHFFFAOYSA-N 0.000 claims 1
- PFKZXDIAFGJXRE-UHFFFAOYSA-N n,1-dimethyl-n-[2-(4-phenyl-4-pyrrolidin-1-ylpiperidin-1-yl)ethyl]indole-6-carboxamide Chemical compound C=1C=C2C=CN(C)C2=CC=1C(=O)N(C)CCN(CC1)CCC1(C=1C=CC=CC=1)N1CCCC1 PFKZXDIAFGJXRE-UHFFFAOYSA-N 0.000 claims 1
- LBWORDJQGWJNIV-UHFFFAOYSA-N n,n-dimethyl-1-[2-[(6-propan-2-yl-1h-indol-3-yl)methylamino]ethyl]-4-thiophen-2-ylpiperidin-4-amine Chemical compound C=1NC2=CC(C(C)C)=CC=C2C=1CNCCN(CC1)CCC1(N(C)C)C1=CC=CS1 LBWORDJQGWJNIV-UHFFFAOYSA-N 0.000 claims 1
- GNPVJIFEFLHDSX-UHFFFAOYSA-N n,n-dimethyl-1-[2-[methyl-[(2-phenyl-1h-indol-3-yl)methyl]amino]ethyl]-4-phenylpiperidin-4-amine Chemical compound C=1C=CC=CC=1C=1NC2=CC=CC=C2C=1CN(C)CCN(CC1)CCC1(N(C)C)C1=CC=CC=C1 GNPVJIFEFLHDSX-UHFFFAOYSA-N 0.000 claims 1
- SYLOJLHNCSMACS-UHFFFAOYSA-N n,n-dimethyl-1-[3-[methyl-[(6-propan-2-yl-1h-indol-3-yl)methyl]amino]propyl]-4-thiophen-2-ylpiperidin-4-amine Chemical compound C=1NC2=CC(C(C)C)=CC=C2C=1CN(C)CCCN(CC1)CCC1(N(C)C)C1=CC=CS1 SYLOJLHNCSMACS-UHFFFAOYSA-N 0.000 claims 1
- UPKPAUGOGQNUBO-UHFFFAOYSA-N n-(1h-indol-3-ylmethyl)-n-methyl-2-(4-phenyl-4-pyrrolidin-1-ylpiperidin-1-yl)ethanamine Chemical compound C=1NC2=CC=CC=C2C=1CN(C)CCN(CC1)CCC1(C=1C=CC=CC=1)N1CCCC1 UPKPAUGOGQNUBO-UHFFFAOYSA-N 0.000 claims 1
- WHPUOCIHYFGMNF-UHFFFAOYSA-N n-(1h-indol-4-ylmethyl)-n-methyl-2-(4-phenyl-4-pyrrolidin-1-ylpiperidin-1-yl)ethanamine Chemical compound C=1C=CC=2NC=CC=2C=1CN(C)CCN(CC1)CCC1(C=1C=CC=CC=1)N1CCCC1 WHPUOCIHYFGMNF-UHFFFAOYSA-N 0.000 claims 1
- VYSSJRDKBQZKTF-UHFFFAOYSA-N n-(1h-indol-5-ylmethyl)-n-methyl-2-(4-phenyl-4-pyrrolidin-1-ylpiperidin-1-yl)ethanamine Chemical compound C=1C=C2NC=CC2=CC=1CN(C)CCN(CC1)CCC1(C=1C=CC=CC=1)N1CCCC1 VYSSJRDKBQZKTF-UHFFFAOYSA-N 0.000 claims 1
- TYQMMKLALSYDTP-UHFFFAOYSA-N n-(1h-indol-6-ylmethyl)-n-methyl-2-(4-phenyl-4-pyrrolidin-1-ylpiperidin-1-yl)ethanamine Chemical compound C=1C=C2C=CNC2=CC=1CN(C)CCN(CC1)CCC1(C=1C=CC=CC=1)N1CCCC1 TYQMMKLALSYDTP-UHFFFAOYSA-N 0.000 claims 1
- SDTUOZUECLIGTA-UHFFFAOYSA-N n-[(5-bromo-1h-indol-3-yl)methyl]-n-methyl-2-(4-phenyl-4-pyrrolidin-1-ylpiperidin-1-yl)ethanamine Chemical compound C=1NC2=CC=C(Br)C=C2C=1CN(C)CCN(CC1)CCC1(C=1C=CC=CC=1)N1CCCC1 SDTUOZUECLIGTA-UHFFFAOYSA-N 0.000 claims 1
- GAABETLKGAITEG-UHFFFAOYSA-N n-[1-[4-(dimethylamino)-4-phenylpiperidin-1-yl]-3-methyl-1-oxobutan-2-yl]-2-(6-fluoro-1h-indol-3-yl)-n-methylacetamide Chemical compound C=1NC2=CC(F)=CC=C2C=1CC(=O)N(C)C(C(C)C)C(=O)N(CC1)CCC1(N(C)C)C1=CC=CC=C1 GAABETLKGAITEG-UHFFFAOYSA-N 0.000 claims 1
- ZPIUGGOAPOKQPV-UHFFFAOYSA-N n-[1-[4-(dimethylamino)-4-phenylpiperidin-1-yl]-3-methyl-1-oxobutan-2-yl]-3-(1h-indol-3-yl)-n-methylpropanamide Chemical compound C=1NC2=CC=CC=C2C=1CCC(=O)N(C)C(C(C)C)C(=O)N(CC1)CCC1(N(C)C)C1=CC=CC=C1 ZPIUGGOAPOKQPV-UHFFFAOYSA-N 0.000 claims 1
- WBRQGMKWLSEVKP-UHFFFAOYSA-N n-[2-[4-(dimethylamino)-4-phenylpiperidin-1-yl]ethyl]-3-(1h-indol-3-yl)-n-methylbutanamide Chemical compound C=1NC2=CC=CC=C2C=1C(C)CC(=O)N(C)CCN(CC1)CCC1(N(C)C)C1=CC=CC=C1 WBRQGMKWLSEVKP-UHFFFAOYSA-N 0.000 claims 1
- UIAJQHBBPBSLKM-UHFFFAOYSA-N n-[2-[4-(dimethylamino)-4-phenylpiperidin-1-yl]ethyl]-3-(1h-indol-3-yl)-n-methylpropanamide Chemical compound C1CN(CCN(C)C(=O)CCC=2C3=CC=CC=C3NC=2)CCC1(N(C)C)C1=CC=CC=C1 UIAJQHBBPBSLKM-UHFFFAOYSA-N 0.000 claims 1
- DRSGCOMYBWFHBZ-UHFFFAOYSA-N n-[2-[4-(dimethylamino)-4-phenylpiperidin-1-yl]ethyl]-n,1-dimethylindole-6-carboxamide Chemical compound C=1C=C2C=CN(C)C2=CC=1C(=O)N(C)CCN(CC1)CCC1(N(C)C)C1=CC=CC=C1 DRSGCOMYBWFHBZ-UHFFFAOYSA-N 0.000 claims 1
- KDANUGPBSZKUOD-UHFFFAOYSA-N n-[2-[4-(dimethylamino)-4-phenylpiperidin-1-yl]ethyl]-n-methyl-1h-indole-3-carboxamide Chemical compound C1CN(CCN(C)C(=O)C=2C3=CC=CC=C3NC=2)CCC1(N(C)C)C1=CC=CC=C1 KDANUGPBSZKUOD-UHFFFAOYSA-N 0.000 claims 1
- ZYLBJKIDORMUGU-UHFFFAOYSA-N n-[2-[4-(dimethylamino)-4-thiophen-2-ylpiperidin-1-yl]-2-oxo-1-phenylethyl]-2-(6-fluoro-1h-indol-3-yl)-n-methylacetamide Chemical compound C1CC(N(C)C)(C=2SC=CC=2)CCN1C(=O)C(N(C)C(=O)CC=1C2=CC=C(F)C=C2NC=1)C1=CC=CC=C1 ZYLBJKIDORMUGU-UHFFFAOYSA-N 0.000 claims 1
- SMKXKSNHHFGICR-UHFFFAOYSA-N n-[2-[4-(dimethylamino)-4-thiophen-2-ylpiperidin-1-yl]-2-oxo-1-phenylethyl]-3-(1h-indol-3-yl)-n,4-dimethylpentanamide Chemical compound C=1NC2=CC=CC=C2C=1C(C(C)C)CC(=O)N(C)C(C=1C=CC=CC=1)C(=O)N(CC1)CCC1(N(C)C)C1=CC=CS1 SMKXKSNHHFGICR-UHFFFAOYSA-N 0.000 claims 1
- VNXITMYPJWWBFD-UHFFFAOYSA-N n-[2-[4-(dimethylamino)-4-thiophen-2-ylpiperidin-1-yl]-2-oxo-1-phenylethyl]-3-(1h-indol-3-yl)-n-methylpropanamide Chemical compound C1CC(N(C)C)(C=2SC=CC=2)CCN1C(=O)C(N(C)C(=O)CCC=1C2=CC=CC=C2NC=1)C1=CC=CC=C1 VNXITMYPJWWBFD-UHFFFAOYSA-N 0.000 claims 1
- QJPALPYRPIBZSR-UHFFFAOYSA-N n-[2-[4-(dimethylamino)-4-thiophen-2-ylpiperidin-1-yl]-2-oxo-1-phenylethyl]-n,1-dimethylindole-6-carboxamide Chemical compound C1CC(N(C)C)(C=2SC=CC=2)CCN1C(=O)C(N(C)C(=O)C=1C=C2N(C)C=CC2=CC=1)C1=CC=CC=C1 QJPALPYRPIBZSR-UHFFFAOYSA-N 0.000 claims 1
- MHJQCCHLMLTKGW-UHFFFAOYSA-N n-[2-[4-(dimethylamino)-4-thiophen-2-ylpiperidin-1-yl]-2-oxo-1-phenylethyl]-n-methyl-1h-indole-6-carboxamide Chemical compound C1CC(N(C)C)(C=2SC=CC=2)CCN1C(=O)C(N(C)C(=O)C=1C=C2NC=CC2=CC=1)C1=CC=CC=C1 MHJQCCHLMLTKGW-UHFFFAOYSA-N 0.000 claims 1
- JOWOSPXBNIZBNA-UHFFFAOYSA-N n-[2-[4-(dimethylamino)-4-thiophen-2-ylpiperidin-1-yl]-2-oxoethyl]-1-methylindole-4-carboxamide Chemical compound C1CN(C(=O)CNC(=O)C=2C=3C=CN(C)C=3C=CC=2)CCC1(N(C)C)C1=CC=CS1 JOWOSPXBNIZBNA-UHFFFAOYSA-N 0.000 claims 1
- HHOAUHAHPCQOHF-UHFFFAOYSA-N n-[2-[4-(dimethylamino)-4-thiophen-2-ylpiperidin-1-yl]-2-oxoethyl]-1-methylindole-6-carboxamide Chemical compound C1CN(C(=O)CNC(=O)C=2C=C3N(C)C=CC3=CC=2)CCC1(N(C)C)C1=CC=CS1 HHOAUHAHPCQOHF-UHFFFAOYSA-N 0.000 claims 1
- PVYPFTSGPZXUHZ-UHFFFAOYSA-N n-[2-[4-(dimethylamino)-4-thiophen-2-ylpiperidin-1-yl]-2-oxoethyl]-3-(1h-indol-3-yl)-4-methylpentanamide Chemical compound C=1NC2=CC=CC=C2C=1C(C(C)C)CC(=O)NCC(=O)N(CC1)CCC1(N(C)C)C1=CC=CS1 PVYPFTSGPZXUHZ-UHFFFAOYSA-N 0.000 claims 1
- PNVPLLLHSRDFHJ-UHFFFAOYSA-N n-[2-[4-(dimethylamino)-4-thiophen-2-ylpiperidin-1-yl]ethyl]-1-methylindole-4-carboxamide Chemical compound C1CN(CCNC(=O)C=2C=3C=CN(C)C=3C=CC=2)CCC1(N(C)C)C1=CC=CS1 PNVPLLLHSRDFHJ-UHFFFAOYSA-N 0.000 claims 1
- QCBPXYNWVMFNKC-UHFFFAOYSA-N n-[2-[4-(dimethylamino)-4-thiophen-2-ylpiperidin-1-yl]ethyl]-1-methylindole-6-carboxamide Chemical compound C1CN(CCNC(=O)C=2C=C3N(C)C=CC3=CC=2)CCC1(N(C)C)C1=CC=CS1 QCBPXYNWVMFNKC-UHFFFAOYSA-N 0.000 claims 1
- KNWJXRAULFZNRB-UHFFFAOYSA-N n-[2-[4-butyl-4-(dimethylamino)piperidin-1-yl]ethyl]-3-(1h-indol-3-yl)-n,4-dimethylpentanamide Chemical compound C1CC(CCCC)(N(C)C)CCN1CCN(C)C(=O)CC(C(C)C)C1=CNC2=CC=CC=C12 KNWJXRAULFZNRB-UHFFFAOYSA-N 0.000 claims 1
- OYIAGNRYBAASMM-UHFFFAOYSA-N n-[2-[4-butyl-4-(dimethylamino)piperidin-1-yl]ethyl]-3-(1h-indol-3-yl)-n-methylbutanamide Chemical compound C1CC(CCCC)(N(C)C)CCN1CCN(C)C(=O)CC(C)C1=CNC2=CC=CC=C12 OYIAGNRYBAASMM-UHFFFAOYSA-N 0.000 claims 1
- MFKASPDBGNVCQS-UHFFFAOYSA-N n-[2-[4-butyl-4-(dimethylamino)piperidin-1-yl]ethyl]-3-(1h-indol-3-yl)-n-methylpropanamide Chemical compound C1CC(CCCC)(N(C)C)CCN1CCN(C)C(=O)CCC1=CNC2=CC=CC=C12 MFKASPDBGNVCQS-UHFFFAOYSA-N 0.000 claims 1
- ZPFNIZCIQOZOPI-UHFFFAOYSA-N n-[2-[4-butyl-4-(dimethylamino)piperidin-1-yl]ethyl]-5-fluoro-n-methyl-1h-indole-2-carboxamide Chemical compound C1CC(CCCC)(N(C)C)CCN1CCN(C)C(=O)C1=CC2=CC(F)=CC=C2N1 ZPFNIZCIQOZOPI-UHFFFAOYSA-N 0.000 claims 1
- SMZARKFYGIYWLB-UHFFFAOYSA-N n-[2-[4-butyl-4-(dimethylamino)piperidin-1-yl]ethyl]-5-methoxy-n-methyl-1h-indole-2-carboxamide Chemical compound C1CC(CCCC)(N(C)C)CCN1CCN(C)C(=O)C1=CC2=CC(OC)=CC=C2N1 SMZARKFYGIYWLB-UHFFFAOYSA-N 0.000 claims 1
- WAOFYSGKNIMWQS-UHFFFAOYSA-N n-[2-[4-butyl-4-(dimethylamino)piperidin-1-yl]ethyl]-6-chloro-n-methyl-2,3,4,9-tetrahydro-1h-carbazole-1-carboxamide Chemical compound C1CC(CCCC)(N(C)C)CCN1CCN(C)C(=O)C1C(NC=2C3=CC(Cl)=CC=2)=C3CCC1 WAOFYSGKNIMWQS-UHFFFAOYSA-N 0.000 claims 1
- KMHITLDUKFOHTP-UHFFFAOYSA-N n-[2-[4-butyl-4-(dimethylamino)piperidin-1-yl]ethyl]-n,1-dimethylindole-4-carboxamide Chemical compound C1CC(CCCC)(N(C)C)CCN1CCN(C)C(=O)C1=CC=CC2=C1C=CN2C KMHITLDUKFOHTP-UHFFFAOYSA-N 0.000 claims 1
- PTMURHVIDHJPCA-UHFFFAOYSA-N n-[2-[4-butyl-4-(dimethylamino)piperidin-1-yl]ethyl]-n,1-dimethylindole-6-carboxamide Chemical compound C1CC(CCCC)(N(C)C)CCN1CCN(C)C(=O)C1=CC=C(C=CN2C)C2=C1 PTMURHVIDHJPCA-UHFFFAOYSA-N 0.000 claims 1
- IKXXRUBDVFRXDP-UHFFFAOYSA-N n-[2-[4-butyl-4-(dimethylamino)piperidin-1-yl]ethyl]-n-methyl-1h-indole-3-carboxamide Chemical compound C1CC(CCCC)(N(C)C)CCN1CCN(C)C(=O)C1=CNC2=CC=CC=C12 IKXXRUBDVFRXDP-UHFFFAOYSA-N 0.000 claims 1
- GLCZPFDEYWMONR-UHFFFAOYSA-N n-[2-[4-butyl-4-(dimethylamino)piperidin-1-yl]ethyl]-n-methyl-1h-indole-6-carboxamide Chemical compound C1CC(CCCC)(N(C)C)CCN1CCN(C)C(=O)C1=CC=C(C=CN2)C2=C1 GLCZPFDEYWMONR-UHFFFAOYSA-N 0.000 claims 1
- XTYBSKXSGFCFBZ-UHFFFAOYSA-N n-[3-[4-(dimethylamino)-4-phenylpiperidin-1-yl]-3-oxopropyl]-1-methylindole-4-carboxamide Chemical compound C1CN(C(=O)CCNC(=O)C=2C=3C=CN(C)C=3C=CC=2)CCC1(N(C)C)C1=CC=CC=C1 XTYBSKXSGFCFBZ-UHFFFAOYSA-N 0.000 claims 1
- QGICUUQRMXEHTM-UHFFFAOYSA-N n-[3-[4-(dimethylamino)-4-phenylpiperidin-1-yl]-3-oxopropyl]-1-methylindole-6-carboxamide Chemical compound C1CN(C(=O)CCNC(=O)C=2C=C3N(C)C=CC3=CC=2)CCC1(N(C)C)C1=CC=CC=C1 QGICUUQRMXEHTM-UHFFFAOYSA-N 0.000 claims 1
- VHJZPFNSWCIEQN-UHFFFAOYSA-N n-[3-[4-(dimethylamino)-4-phenylpiperidin-1-yl]-3-oxopropyl]-1h-indole-6-carboxamide Chemical compound C1CN(C(=O)CCNC(=O)C=2C=C3NC=CC3=CC=2)CCC1(N(C)C)C1=CC=CC=C1 VHJZPFNSWCIEQN-UHFFFAOYSA-N 0.000 claims 1
- LNGWPRJVFQFWJY-UHFFFAOYSA-N n-[3-[4-(dimethylamino)-4-phenylpiperidin-1-yl]-3-oxopropyl]-3-(1h-indol-3-yl)-4-methylpentanamide Chemical compound C=1NC2=CC=CC=C2C=1C(C(C)C)CC(=O)NCCC(=O)N(CC1)CCC1(N(C)C)C1=CC=CC=C1 LNGWPRJVFQFWJY-UHFFFAOYSA-N 0.000 claims 1
- KYPHPSYQIKVNMB-UHFFFAOYSA-N n-[3-[4-(dimethylamino)-4-phenylpiperidin-1-yl]-3-oxopropyl]-3-(1h-indol-3-yl)propanamide Chemical compound C1CN(C(=O)CCNC(=O)CCC=2C3=CC=CC=C3NC=2)CCC1(N(C)C)C1=CC=CC=C1 KYPHPSYQIKVNMB-UHFFFAOYSA-N 0.000 claims 1
- UXBIZBXKQYVXKB-UHFFFAOYSA-N n-[3-[4-(dimethylamino)-4-phenylpiperidin-1-yl]-3-oxopropyl]-5-methoxy-1h-indole-2-carboxamide Chemical compound C=1C2=CC(OC)=CC=C2NC=1C(=O)NCCC(=O)N(CC1)CCC1(N(C)C)C1=CC=CC=C1 UXBIZBXKQYVXKB-UHFFFAOYSA-N 0.000 claims 1
- CDALWQDFEJPJMZ-UHFFFAOYSA-N n-[3-[4-(dimethylamino)-4-phenylpiperidin-1-yl]propyl]-2-(6-fluoro-1h-indol-3-yl)-n-methylacetamide Chemical compound C1CN(CCCN(C)C(=O)CC=2C3=CC=C(F)C=C3NC=2)CCC1(N(C)C)C1=CC=CC=C1 CDALWQDFEJPJMZ-UHFFFAOYSA-N 0.000 claims 1
- KUYYCSJWWQQZDN-UHFFFAOYSA-N n-[3-[4-(dimethylamino)-4-phenylpiperidin-1-yl]propyl]-3-(1h-indol-3-yl)-n,4-dimethylpentanamide Chemical compound C=1NC2=CC=CC=C2C=1C(C(C)C)CC(=O)N(C)CCCN(CC1)CCC1(N(C)C)C1=CC=CC=C1 KUYYCSJWWQQZDN-UHFFFAOYSA-N 0.000 claims 1
- YIWJJFHLJUYFOE-UHFFFAOYSA-N n-[3-[4-(dimethylamino)-4-phenylpiperidin-1-yl]propyl]-3-(1h-indol-3-yl)-n-methylbutanamide Chemical compound C=1NC2=CC=CC=C2C=1C(C)CC(=O)N(C)CCCN(CC1)CCC1(N(C)C)C1=CC=CC=C1 YIWJJFHLJUYFOE-UHFFFAOYSA-N 0.000 claims 1
- NKRUDLBDHSUMHC-UHFFFAOYSA-N n-[3-[4-(dimethylamino)-4-phenylpiperidin-1-yl]propyl]-3-(1h-indol-3-yl)-n-methylpropanamide Chemical compound C1CN(CCCN(C)C(=O)CCC=2C3=CC=CC=C3NC=2)CCC1(N(C)C)C1=CC=CC=C1 NKRUDLBDHSUMHC-UHFFFAOYSA-N 0.000 claims 1
- AZFWIKXSFCNGKO-UHFFFAOYSA-N n-[3-[4-(dimethylamino)-4-phenylpiperidin-1-yl]propyl]-5-fluoro-n-methyl-1h-indole-2-carboxamide Chemical compound C1CN(CCCN(C)C(=O)C=2NC3=CC=C(F)C=C3C=2)CCC1(N(C)C)C1=CC=CC=C1 AZFWIKXSFCNGKO-UHFFFAOYSA-N 0.000 claims 1
- FUYDOVYKTUVZPG-UHFFFAOYSA-N n-[3-[4-(dimethylamino)-4-phenylpiperidin-1-yl]propyl]-5-methoxy-n-methyl-1h-indole-2-carboxamide Chemical compound C=1C2=CC(OC)=CC=C2NC=1C(=O)N(C)CCCN(CC1)CCC1(N(C)C)C1=CC=CC=C1 FUYDOVYKTUVZPG-UHFFFAOYSA-N 0.000 claims 1
- AUNRTQYRVMMBMW-UHFFFAOYSA-N n-[3-[4-(dimethylamino)-4-phenylpiperidin-1-yl]propyl]-n,1-dimethylindole-6-carboxamide Chemical compound C=1C=C2C=CN(C)C2=CC=1C(=O)N(C)CCCN(CC1)CCC1(N(C)C)C1=CC=CC=C1 AUNRTQYRVMMBMW-UHFFFAOYSA-N 0.000 claims 1
- PZCMWHFSGXZJIQ-UHFFFAOYSA-N n-[3-[4-(dimethylamino)-4-phenylpiperidin-1-yl]propyl]-n-methyl-1h-indole-6-carboxamide Chemical compound C1CN(CCCN(C)C(=O)C=2C=C3NC=CC3=CC=2)CCC1(N(C)C)C1=CC=CC=C1 PZCMWHFSGXZJIQ-UHFFFAOYSA-N 0.000 claims 1
- UUINSZJHKNDHJE-UHFFFAOYSA-N n-[3-[4-(dimethylamino)-4-thiophen-2-ylpiperidin-1-yl]-3-oxo-1-phenylpropyl]-1-methylindole-4-carboxamide Chemical compound C1CC(N(C)C)(C=2SC=CC=2)CCN1C(=O)CC(NC(=O)C=1C=2C=CN(C)C=2C=CC=1)C1=CC=CC=C1 UUINSZJHKNDHJE-UHFFFAOYSA-N 0.000 claims 1
- NSNDQWKRCDZOGF-UHFFFAOYSA-N n-[3-[4-(dimethylamino)-4-thiophen-2-ylpiperidin-1-yl]-3-oxo-1-phenylpropyl]-1-methylindole-6-carboxamide Chemical compound C1CC(N(C)C)(C=2SC=CC=2)CCN1C(=O)CC(NC(=O)C=1C=C2N(C)C=CC2=CC=1)C1=CC=CC=C1 NSNDQWKRCDZOGF-UHFFFAOYSA-N 0.000 claims 1
- DRRVWYOGVMYIGT-UHFFFAOYSA-N n-[3-[4-(dimethylamino)-4-thiophen-2-ylpiperidin-1-yl]-3-oxo-1-phenylpropyl]-1h-indole-6-carboxamide Chemical compound C1CC(N(C)C)(C=2SC=CC=2)CCN1C(=O)CC(NC(=O)C=1C=C2NC=CC2=CC=1)C1=CC=CC=C1 DRRVWYOGVMYIGT-UHFFFAOYSA-N 0.000 claims 1
- KYFSKWCCMKARSR-UHFFFAOYSA-N n-[3-[4-(dimethylamino)-4-thiophen-2-ylpiperidin-1-yl]-3-oxo-1-phenylpropyl]-3-(1h-indol-3-yl)-4-methylpentanamide Chemical compound C=1NC2=CC=CC=C2C=1C(C(C)C)CC(=O)NC(C=1C=CC=CC=1)CC(=O)N(CC1)CCC1(N(C)C)C1=CC=CS1 KYFSKWCCMKARSR-UHFFFAOYSA-N 0.000 claims 1
- CVNHJLLTKIUHQC-UHFFFAOYSA-N n-[3-[4-(dimethylamino)-4-thiophen-2-ylpiperidin-1-yl]propyl]-2-(6-fluoro-1h-indol-3-yl)-n-methylacetamide Chemical compound C1CN(CCCN(C)C(=O)CC=2C3=CC=C(F)C=C3NC=2)CCC1(N(C)C)C1=CC=CS1 CVNHJLLTKIUHQC-UHFFFAOYSA-N 0.000 claims 1
- FZMBEKXWDVRUJH-UHFFFAOYSA-N n-[3-[4-(dimethylamino)-4-thiophen-2-ylpiperidin-1-yl]propyl]-3-(1h-indol-3-yl)-n,4-dimethylpentanamide Chemical compound C=1NC2=CC=CC=C2C=1C(C(C)C)CC(=O)N(C)CCCN(CC1)CCC1(N(C)C)C1=CC=CS1 FZMBEKXWDVRUJH-UHFFFAOYSA-N 0.000 claims 1
- CSBJIVRXMQZCCJ-UHFFFAOYSA-N n-[3-[4-(dimethylamino)-4-thiophen-2-ylpiperidin-1-yl]propyl]-3-(1h-indol-3-yl)-n-methylbutanamide Chemical compound C=1NC2=CC=CC=C2C=1C(C)CC(=O)N(C)CCCN(CC1)CCC1(N(C)C)C1=CC=CS1 CSBJIVRXMQZCCJ-UHFFFAOYSA-N 0.000 claims 1
- DMYHYIJJGIAJNA-UHFFFAOYSA-N n-[3-[4-(dimethylamino)-4-thiophen-2-ylpiperidin-1-yl]propyl]-3-(1h-indol-3-yl)-n-methylpropanamide Chemical compound C1CN(CCCN(C)C(=O)CCC=2C3=CC=CC=C3NC=2)CCC1(N(C)C)C1=CC=CS1 DMYHYIJJGIAJNA-UHFFFAOYSA-N 0.000 claims 1
- CZFOXBDTXZWTTA-UHFFFAOYSA-N n-[3-[4-(dimethylamino)-4-thiophen-2-ylpiperidin-1-yl]propyl]-5-methoxy-n-methyl-1h-indole-2-carboxamide Chemical compound C=1C2=CC(OC)=CC=C2NC=1C(=O)N(C)CCCN(CC1)CCC1(N(C)C)C1=CC=CS1 CZFOXBDTXZWTTA-UHFFFAOYSA-N 0.000 claims 1
- AAXNKGAAWBMLOD-UHFFFAOYSA-N n-[3-[4-(dimethylamino)-4-thiophen-2-ylpiperidin-1-yl]propyl]-n,1-dimethylindole-4-carboxamide Chemical compound C=1C=CC=2N(C)C=CC=2C=1C(=O)N(C)CCCN(CC1)CCC1(N(C)C)C1=CC=CS1 AAXNKGAAWBMLOD-UHFFFAOYSA-N 0.000 claims 1
- HBEYVGSNZMPYTN-UHFFFAOYSA-N n-[3-[4-(dimethylamino)-4-thiophen-2-ylpiperidin-1-yl]propyl]-n,1-dimethylindole-6-carboxamide Chemical compound C=1C=C2C=CN(C)C2=CC=1C(=O)N(C)CCCN(CC1)CCC1(N(C)C)C1=CC=CS1 HBEYVGSNZMPYTN-UHFFFAOYSA-N 0.000 claims 1
- TUJIEIMFVPLVBB-UHFFFAOYSA-N n-[3-[4-(dimethylamino)-4-thiophen-2-ylpiperidin-1-yl]propyl]-n-methyl-1h-indole-3-carboxamide Chemical compound C1CN(CCCN(C)C(=O)C=2C3=CC=CC=C3NC=2)CCC1(N(C)C)C1=CC=CS1 TUJIEIMFVPLVBB-UHFFFAOYSA-N 0.000 claims 1
- WNXBAJLYLKOQPR-UHFFFAOYSA-N n-[3-[4-(dimethylamino)-4-thiophen-2-ylpiperidin-1-yl]propyl]-n-methyl-1h-indole-6-carboxamide Chemical compound C1CN(CCCN(C)C(=O)C=2C=C3NC=CC3=CC=2)CCC1(N(C)C)C1=CC=CS1 WNXBAJLYLKOQPR-UHFFFAOYSA-N 0.000 claims 1
- 125000004108 n-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 claims 1
- 125000001280 n-hexyl group Chemical group C(CCCCC)* 0.000 claims 1
- NOWKSZRSMXHPHY-UHFFFAOYSA-N n-methyl-n-[2-(4-phenyl-4-pyrrolidin-1-ylpiperidin-1-yl)ethyl]-1h-indole-3-carboxamide Chemical compound C=1NC2=CC=CC=C2C=1C(=O)N(C)CCN(CC1)CCC1(C=1C=CC=CC=1)N1CCCC1 NOWKSZRSMXHPHY-UHFFFAOYSA-N 0.000 claims 1
- YLLVZWAITXFEII-UHFFFAOYSA-N n-methyl-n-[2-(4-phenyl-4-pyrrolidin-1-ylpiperidin-1-yl)ethyl]-1h-indole-6-carboxamide Chemical compound C=1C=C2C=CNC2=CC=1C(=O)N(C)CCN(CC1)CCC1(C=1C=CC=CC=1)N1CCCC1 YLLVZWAITXFEII-UHFFFAOYSA-N 0.000 claims 1
- 125000000740 n-pentyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 claims 1
- 125000004123 n-propyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])* 0.000 claims 1
- 125000001971 neopentyl group Chemical group [H]C([*])([H])C(C([H])([H])[H])(C([H])([H])[H])C([H])([H])[H] 0.000 claims 1
- 208000004296 neuralgia Diseases 0.000 claims 1
- 230000004770 neurodegeneration Effects 0.000 claims 1
- 208000015122 neurodegenerative disease Diseases 0.000 claims 1
- 230000002981 neuropathic effect Effects 0.000 claims 1
- 208000021722 neuropathic pain Diseases 0.000 claims 1
- 230000003957 neurotransmitter release Effects 0.000 claims 1
- 239000002664 nootropic agent Substances 0.000 claims 1
- 235000020824 obesity Nutrition 0.000 claims 1
- 150000007530 organic bases Chemical class 0.000 claims 1
- 229910052760 oxygen Inorganic materials 0.000 claims 1
- 239000001301 oxygen Substances 0.000 claims 1
- 125000003367 polycyclic group Chemical group 0.000 claims 1
- UFUASNAHBMBJIX-UHFFFAOYSA-N propan-1-one Chemical compound CC[C]=O UFUASNAHBMBJIX-UHFFFAOYSA-N 0.000 claims 1
- 125000004076 pyridyl group Chemical group 0.000 claims 1
- 125000002914 sec-butyl group Chemical group [H]C([H])([H])C([H])([H])C([H])(*)C([H])([H])[H] 0.000 claims 1
- 231100000872 sexual dysfunction Toxicity 0.000 claims 1
- 239000012279 sodium borohydride Substances 0.000 claims 1
- 229910000033 sodium borohydride Inorganic materials 0.000 claims 1
- BEOOHQFXGBMRKU-UHFFFAOYSA-N sodium cyanoborohydride Chemical compound [Na+].[B-]C#N BEOOHQFXGBMRKU-UHFFFAOYSA-N 0.000 claims 1
- 239000012321 sodium triacetoxyborohydride Substances 0.000 claims 1
- 239000002904 solvent Substances 0.000 claims 1
- 201000009032 substance abuse Diseases 0.000 claims 1
- 229910052717 sulfur Inorganic materials 0.000 claims 1
- 239000011593 sulfur Substances 0.000 claims 1
- YBBRCQOCSYXUOC-UHFFFAOYSA-N sulfuryl dichloride Chemical class ClS(Cl)(=O)=O YBBRCQOCSYXUOC-UHFFFAOYSA-N 0.000 claims 1
- 208000011580 syndromic disease Diseases 0.000 claims 1
- 125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 claims 1
- 125000000335 thiazolyl group Chemical group 0.000 claims 1
- 125000001544 thienyl group Chemical group 0.000 claims 1
- 231100000886 tinnitus Toxicity 0.000 claims 1
- 108020001612 μ-opioid receptors Proteins 0.000 claims 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/12—Antidiarrhoeals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/02—Drugs for disorders of the urinary system of urine or of the urinary tract, e.g. urine acidifiers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/04—Antipruritics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P21/00—Drugs for disorders of the muscular or neuromuscular system
- A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P23/00—Anaesthetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/06—Antimigraine agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
- A61P25/12—Antiepileptics; Anticonvulsants for grand-mal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
- A61P25/32—Alcohol-abuse
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/16—Otologicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A61P29/02—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID] without antiinflammatory effect
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/10—Antioedematous agents; Diuretics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/02—Non-specific cardiovascular stimulants, e.g. drugs for syncope, antihypotensives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Pain & Pain Management (AREA)
- Psychiatry (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Addiction (AREA)
- Urology & Nephrology (AREA)
- Anesthesiology (AREA)
- Vascular Medicine (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Rheumatology (AREA)
- Child & Adolescent Psychology (AREA)
- Obesity (AREA)
- Dermatology (AREA)
- Nutrition Science (AREA)
- Hospice & Palliative Care (AREA)
- Physical Education & Sports Medicine (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP08003238 | 2008-02-22 | ||
| EP08003238.6 | 2008-02-22 | ||
| PCT/EP2009/001232 WO2009103552A1 (en) | 2008-02-22 | 2009-02-20 | Substituted indole derivatives |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| RU2010138838A RU2010138838A (ru) | 2012-03-27 |
| RU2500677C2 true RU2500677C2 (ru) | 2013-12-10 |
Family
ID=39449548
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| RU2010138838/04A RU2500677C2 (ru) | 2008-02-22 | 2009-02-20 | Производные замещенного индола |
Country Status (13)
| Country | Link |
|---|---|
| US (2) | US20090215828A1 (https=) |
| EP (1) | EP2254883B1 (https=) |
| JP (1) | JP5635914B2 (https=) |
| CN (1) | CN102015683B (https=) |
| AR (1) | AR070398A1 (https=) |
| AU (1) | AU2009216920B2 (https=) |
| CA (1) | CA2716270C (https=) |
| CL (1) | CL2009000404A1 (https=) |
| IL (1) | IL207684A (https=) |
| MX (1) | MX2010009045A (https=) |
| PE (1) | PE20091490A1 (https=) |
| RU (1) | RU2500677C2 (https=) |
| WO (1) | WO2009103552A1 (https=) |
Families Citing this family (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AR070398A1 (es) | 2008-02-22 | 2010-03-31 | Gruenenthal Chemie | Derivados sustituidos de indol |
| EA019252B1 (ru) | 2008-07-23 | 2014-02-28 | Арена Фармасьютикалз, Инк. | ЗАМЕЩЕННЫЕ ПРОИЗВОДНЫЕ (1,2,3,4-ТЕТРАГИДРОЦИКЛОПЕНТА[b]ИНДОЛ-3-ИЛ)УКСУСНОЙ КИСЛОТЫ, ПРИМЕНИМЫЕ В ЛЕЧЕНИИ АУТОИММУННЫХ И ВОСПАЛИТЕЛЬНЫХ РАССТРОЙСТВ |
| SI2342205T1 (sl) | 2008-08-27 | 2016-09-30 | Arena Pharmaceuticals, Inc. | Substituirani triciklični kislinski derivati kot agonisti S1P1 receptorja, uporabni v zdravljenju avtoimunskih in vnetnih obolenj |
| TW201020247A (en) * | 2008-11-06 | 2010-06-01 | Gruenenthal Gmbh | Substituierte disulfonamide |
| SG10201906876PA (en) | 2010-01-27 | 2019-09-27 | Arena Pharm Inc | Processes for the preparation of (r)-2-(7-(4-cyclopentyl-3-(trifluoromethyl)benzyloxy)-1,2,3,4-tetrahydrocyclopenta[b]indol-3-yl)acetic acid and salts thereof |
| SG183416A1 (en) | 2010-03-03 | 2012-09-27 | Arena Pharm Inc | Processes for the preparation of s1p1 receptor modulators and crystalline forms thereof |
| UA110112C2 (uk) | 2010-05-07 | 2015-11-25 | Глаксосмітклайн Ллс | Індоли |
| BR112014010803A2 (pt) | 2011-11-04 | 2017-04-25 | Glaxosmithkline Intellectual Property (No 2) Ltd | método de tratamento |
| JO3425B1 (ar) | 2013-07-15 | 2019-10-20 | Novartis Ag | مشتقات البابيريدينيل-اندول واستخدامها كعامل متمم لمثبطات b |
| MX386419B (es) | 2015-01-06 | 2025-03-18 | Arena Pharm Inc | Metodos de condiciones de tratamiento relacionadas con el receptor s1p1. |
| EP3939965A1 (en) | 2015-06-22 | 2022-01-19 | Arena Pharmaceuticals, Inc. | Crystalline l-arginine salt of (r)-2-(7-(4-cyclopentyl-3-(trifluoromethyl)benzyloxy)-1,2,3,4-tetrahydrocyclo-penta[b]indol-3-yl)acetic acid for use in sipi receptor-associated disorders |
| WO2018093698A1 (en) | 2016-11-18 | 2018-05-24 | Merck Sharp & Dohme Corp. | Indole derivatives useful as inhibitors of diacylglyceride o-acyltransferase 2 |
| WO2018151834A1 (en) | 2017-02-16 | 2018-08-23 | Arena Pharmaceuticals, Inc. | Compounds and methods for treatment of inflammatory bowel disease with extra-intestinal manifestations |
| MA47504A (fr) | 2017-02-16 | 2019-12-25 | Arena Pharm Inc | Composés et méthodes de traitement de l'angiocholite biliaire primitive |
| CN110770224B (zh) * | 2017-03-10 | 2022-11-18 | 罗格斯新泽西州立大学 | 作为外排泵抑制剂的吲哚衍生物 |
| ES2987794T3 (es) | 2018-06-06 | 2024-11-18 | Arena Pharm Inc | Procedimientos de tratamiento de afecciones relacionadas con el receptor S1P1 |
| CN112955431A (zh) | 2018-09-06 | 2021-06-11 | 艾尼纳制药公司 | 可用于治疗自身免疫性病症和炎性病症的化合物 |
| US20240408064A1 (en) * | 2021-10-15 | 2024-12-12 | Genetolead Inc. | Ras inhibitors, compositions and methods of use thereof |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SU1110380A3 (ru) * | 1977-12-01 | 1984-08-23 | Джон Вайс Энд Бразер Лимитед (Фирма) | Способ получени производных индола или их аддитивных солей |
| EP1242411B1 (en) * | 1999-12-20 | 2006-03-08 | Eli Lilly And Company | Indole derivatives for the treatment of depression and anxiety |
| RU2007147591A (ru) * | 2005-05-26 | 2009-07-10 | Новартис АГ (CH) | 3, 4-замещенные пиперидины в качестве ингибиторов ренина |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2224062C (en) * | 1995-06-06 | 2001-09-04 | Pfizer Limited | Substituted n-(indole-2-carbonyl)-glycinamides and derivatives as glycogen phosphorylase inhibitors |
| DE10153346A1 (de) | 2001-10-29 | 2004-04-22 | Grünenthal GmbH | Substituierte Indole |
| DE10252650A1 (de) | 2002-11-11 | 2004-05-27 | Grünenthal GmbH | Cyclohexyl-Harnstoff-Derivate |
| DE10252666A1 (de) * | 2002-11-11 | 2004-08-05 | Grünenthal GmbH | N-Piperidyl-cyclohexan-Derivate |
| WO2005047253A1 (en) * | 2003-11-12 | 2005-05-26 | Lg Life Sciences Ltd. | Melanocortin receptor agonists |
| US20070219214A1 (en) * | 2006-02-01 | 2007-09-20 | Solvay Pharmaceuticals Gmbh | Dual NK2/NK3-antagonists, pharmaceutical compositions comprising them, and processes for their preparation |
| EP1979319A1 (en) * | 2006-02-01 | 2008-10-15 | Solvay Pharmaceuticals GmbH | Novel dual nk2/nk3-antagonists, pharmaceutical compositions comprising them and processes for their preparations |
| CA2682483A1 (en) * | 2007-03-29 | 2008-10-09 | Novartis Ag | 3-imidazolyl-indoles for the treatment of proliferative diseases |
| AR070398A1 (es) | 2008-02-22 | 2010-03-31 | Gruenenthal Chemie | Derivados sustituidos de indol |
-
2009
- 2009-02-16 AR ARP090100544A patent/AR070398A1/es not_active Application Discontinuation
- 2009-02-19 US US12/388,977 patent/US20090215828A1/en not_active Abandoned
- 2009-02-20 CL CL2009000404A patent/CL2009000404A1/es unknown
- 2009-02-20 CN CN200980115064.3A patent/CN102015683B/zh not_active Expired - Fee Related
- 2009-02-20 JP JP2010547116A patent/JP5635914B2/ja not_active Expired - Fee Related
- 2009-02-20 RU RU2010138838/04A patent/RU2500677C2/ru not_active IP Right Cessation
- 2009-02-20 WO PCT/EP2009/001232 patent/WO2009103552A1/en not_active Ceased
- 2009-02-20 MX MX2010009045A patent/MX2010009045A/es active IP Right Grant
- 2009-02-20 CA CA2716270A patent/CA2716270C/en not_active Expired - Fee Related
- 2009-02-20 PE PE2009000247A patent/PE20091490A1/es not_active Application Discontinuation
- 2009-02-20 EP EP09713555.2A patent/EP2254883B1/en not_active Not-in-force
- 2009-02-20 AU AU2009216920A patent/AU2009216920B2/en not_active Ceased
-
2010
- 2010-08-19 IL IL207684A patent/IL207684A/en not_active IP Right Cessation
-
2012
- 2012-12-11 US US13/710,604 patent/US9206156B2/en not_active Expired - Fee Related
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SU1110380A3 (ru) * | 1977-12-01 | 1984-08-23 | Джон Вайс Энд Бразер Лимитед (Фирма) | Способ получени производных индола или их аддитивных солей |
| EP1242411B1 (en) * | 1999-12-20 | 2006-03-08 | Eli Lilly And Company | Indole derivatives for the treatment of depression and anxiety |
| RU2007147591A (ru) * | 2005-05-26 | 2009-07-10 | Новартис АГ (CH) | 3, 4-замещенные пиперидины в качестве ингибиторов ренина |
Also Published As
| Publication number | Publication date |
|---|---|
| US20130116283A1 (en) | 2013-05-09 |
| RU2010138838A (ru) | 2012-03-27 |
| MX2010009045A (es) | 2010-09-24 |
| CA2716270A1 (en) | 2009-08-27 |
| CN102015683A (zh) | 2011-04-13 |
| CN102015683B (zh) | 2015-08-05 |
| HK1149762A1 (en) | 2011-10-14 |
| US20090215828A1 (en) | 2009-08-27 |
| WO2009103552A1 (en) | 2009-08-27 |
| AR070398A1 (es) | 2010-03-31 |
| AU2009216920B2 (en) | 2013-06-13 |
| IL207684A (en) | 2015-08-31 |
| US9206156B2 (en) | 2015-12-08 |
| CL2009000404A1 (es) | 2010-04-16 |
| CA2716270C (en) | 2016-01-19 |
| PE20091490A1 (es) | 2009-09-26 |
| EP2254883B1 (en) | 2014-11-26 |
| EP2254883A1 (en) | 2010-12-01 |
| AU2009216920A1 (en) | 2009-08-27 |
| JP5635914B2 (ja) | 2014-12-03 |
| IL207684A0 (en) | 2010-12-30 |
| JP2011512374A (ja) | 2011-04-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| RU2500677C2 (ru) | Производные замещенного индола | |
| RU2459806C2 (ru) | Замещенные гетероарильные производные | |
| CN101341149B (zh) | 经色原烷取代的苯并咪唑类和它们作为酸泵抑制剂的用途 | |
| US7368470B2 (en) | Substituted 3-pyrrolidine-indole derivatives | |
| ES2309373T3 (es) | Derivados de 1-aminociclohexano-4-sustituidos utiles como ligandos del receptor orl1 y del receptor mu-opioide. | |
| ES2307902T3 (es) | Derivados de indolina e indol 1-arilsulfonil-3- sustituidos utilizados en el tratamiento de transtornos del sistema nervioso central. | |
| AU2007227681A1 (en) | N-substituted-azacyclylamines as histamine-3 antagonists | |
| CZ20032644A3 (en) | Cyclopropylindole derivatives as selective serotonin reuptake inhibitors | |
| JP2012111761A (ja) | カンナビノイド受容体リガンドとしての３−シクロアルキルカルボニルインドール類 | |
| ES2544488T3 (es) | Derivados de (hetero)aril-ciclohexano | |
| CN101910126B (zh) | 作为大麻素受体之配体的脯氨酸类似物 | |
| US8129424B2 (en) | Indole derivatives as histamine 3 receptor inhibitors for the treatment of cognitive and sleep disorders, obesity and other CNS disorders | |
| JP5073758B2 (ja) | Ｎｋ３アンタゴニストとしてのスピロピペリジン誘導体 | |
| NZ277483A (en) | 1-arylindole derivatives and medicaments | |
| RU2009124111A (ru) | Индолы | |
| HK1149762B (en) | Substituted indole derivatives | |
| HK1122497B (en) | Indole derivatives as histamine 3 receptor inhibitors for the treatment of cognitive and sleep disorders, obesity and other cns disorders |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MM4A | The patent is invalid due to non-payment of fees |
Effective date: 20190221 |